<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80647</article-id><article-id pub-id-type="doi">10.7554/eLife.80647</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Neutral amino acid transporter SLC38A2 protects renal medulla from hyperosmolarity-induced ferroptosis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-281475"><name><surname>Du</surname><given-names>Chunxiu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4152-4663</contrib-id><email>chunxiu_du@163.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283589"><name><surname>Xu</surname><given-names>Hu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1198-0932</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283590"><name><surname>Cao</surname><given-names>Cong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283591"><name><surname>Cao</surname><given-names>Jiahui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283592"><name><surname>Zhang</surname><given-names>Yufei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6289-8758</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283593"><name><surname>Zhang</surname><given-names>Cong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283594"><name><surname>Qiao</surname><given-names>Rongfang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283631"><name><surname>Ming</surname><given-names>Wenhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283596"><name><surname>Li</surname><given-names>Yaqing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-235930"><name><surname>Ren</surname><given-names>Huiwen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6037-8561</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283597"><name><surname>Cui</surname><given-names>Xiaohui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283598"><name><surname>Luan</surname><given-names>Zhilin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283613"><name><surname>Guan</surname><given-names>Youfei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5231-0209</contrib-id><email>youfeiguan@163.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283898"><name><surname>Zhang</surname><given-names>Xiaoyan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4060-2423</contrib-id><email>xyzhang@hsc.ecnu.edu.cn</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04c8eg608</institution-id><institution>Advanced Institute for Medical Sciences, Dalian Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Dalian</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04c8eg608</institution-id><institution>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Dalian Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Dalian</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution>Dalian Key Laboratory for Nuclear Receptors in Major Metabolic Diseases</institution><addr-line><named-content content-type="city">Dalian</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02n96ep67</institution-id><institution>Health Science Center, East China Normal University</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zeidel</surname><given-names>Mark L</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04drvxt59</institution-id><institution>Beth Israel Deaconess Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pollak</surname><given-names>Martin R</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>01</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e80647</elocation-id><history><date date-type="received" iso-8601-date="2022-05-28"><day>28</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-01-31"><day>31</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Du et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Du et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80647-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-80647-figures-v2.pdf"/><abstract><p>Hyperosmolarity of the renal medulla is essential for urine concentration and water homeostasis. However, how renal medullary collecting duct (MCD) cells survive and function under harsh hyperosmotic stress remains unclear. Using RNA-Seq, we identified SLC38A2 as a novel osmoresponsive neutral amino acid transporter in MCD cells. Hyperosmotic stress-induced cell death in MCD cells occurred mainly via ferroptosis, and it was significantly attenuated by SLC38A2 overexpression but worsened by <italic>Slc38a2</italic>-gene deletion or silencing. Mechanistic studies revealed that the osmoprotective effect of SLC38A2 is dependent on the activation of mTORC1. Moreover, an in vivo study demonstrated that <italic>Slc38a2</italic>-knockout mice exhibited significantly increased medullary ferroptosis following water restriction. Collectively, these findings reveal that <italic>Slc38a2</italic> is an important osmoresponsive gene in the renal medulla and provide novel insights into the critical role of SLC38A2 in protecting MCD cells from hyperosmolarity-induced ferroptosis via the mTORC1 signalling pathway.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hypertonicity</kwd><kwd>SLC38A2</kwd><kwd>mTORC1</kwd><kwd>ferroptosis</kwd><kwd>medullary collecting duct</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82270703</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xiaoyan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81970606</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xiaoyan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81970595</award-id><principal-award-recipient><name><surname>Guan</surname><given-names>Youfei</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2020YFC2005000</award-id><principal-award-recipient><name><surname>Guan</surname><given-names>Youfei</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004106</institution-id><institution>East China Normal University</institution></institution-wrap></funding-source><award-id>2022JKXYD03001</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xiaoyan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The neutral amino acid transporter SLC38A2 is an essential protective factor for renal medulla during urine concentration.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The kidney is a central organ that maintains body water and electrolyte homeostasis by producing urine, which depends on the establishment and maintenance of osmotic pressure gradient in the renal medulla. In the human kidney, the osmotic pressure of the inner medulla can reach up to 1200 mOsm, which is fourfold higher than that in the plasma. Renal medullary cells, particularly inner medullary collecting duct (IMCD) epithelial cells, must adapt to constant changes in the osmolarity of their environment. Under dehydrated conditions, IMCD cells are exposed to hyperosmotic stress, which frequently causes cell injury and death. IMCD cells must adapt to and withstand external hyperosmolarity to maintain cell viability and fulfil their functions. It has been previously reported that under hyperosmotic conditions, renal medullary cells undergo various forms of cell death, such as necrosis and apoptosis (<xref ref-type="bibr" rid="bib15">Han et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Alfieri et al., 2002</xref>). However, the major form of cell death responsible for hyperosmolarity-induced renal medullary cell injury remains largely unknown. In addition, multiple mechanisms have been demonstrated to contribute to the maintenance of cell viability of renal medullary cells under dehydrated conditions. Among these, the transcription factor tonicity-responsive enhancer binding protein (TonEBP) and its target osmoprotective genes, including aldose reductase and heat shock protein 70 (HSP70), represents the most important protective mechanisms (<xref ref-type="bibr" rid="bib22">Lee et al., 2011</xref>). Other factors, including nuclear factor kappa B (NF-κB), farnesoid X receptor (FXR), peroxisome proliferator-activated receptor β/δ (PPARβ/δ), and cyclooxygenase 2 (COX-2), have also been reported to contribute to the survival of renal medullary cells in a hyperosmotic environment (<xref ref-type="bibr" rid="bib16">Hasler et al., 2008</xref>; <xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Guan, 2004</xref>; <xref ref-type="bibr" rid="bib26">Moeckel et al., 2003</xref>). However, the underlying mechanism by which hyperosmolarity induces medullary cell injury and cell survival under hyperosmotic stress remains incompletely understood and requires further investigation.</p><p>Regulated cell death (RCD) is required for the normal development and maintenance of organ homeostasis. RCD signalling cascades, including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death, are tightly regulated to establish a functional tissue architecture (<xref ref-type="bibr" rid="bib33">Santagostino et al., 2021</xref>). Unlike most other cells that live under isosmotic conditions, medullary collecting duct (MCD) cells reside in an environment of variable hyperosmolarity, which frequently causes cell damage and even death. Ferroptosis is a novel type of RCD that differs from apoptosis, pyroptosis, cell necrosis, and autophagy (<xref ref-type="bibr" rid="bib23">Li et al., 2020</xref>). It is driven by iron-dependent oxidative destruction of the lipid bilayer and is caused by an imbalance of oxidation and antioxidation in cells (<xref ref-type="bibr" rid="bib41">Yan et al., 2021</xref>). Emerging evidence suggests that hyperosmolarity results in a robust increase in reactive oxygen species (ROS) production (<xref ref-type="bibr" rid="bib42">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib19">Ikari et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Ma et al., 2019</xref>), suggesting that ferroptosis may contribute to cell damage and death of renal medullary cells under dehydration conditions. However, the role and mechanism of ferroptosis in the survival of MCD and interstitial cells under hyperosmotic conditions are currently unclear.</p><p>Unrestrained lipid peroxidation is a hallmark of ferroptosis. The reduction of lipid peroxidation to hydroxyl by glutathione peroxidase4 (GPX4) requires the catalytic selenocysteine residue of GPX4 and two electrons provided mainly by glutathione (GSH) (<xref ref-type="bibr" rid="bib20">Jiang et al., 2021</xref>). Cysteine (Cys) is the rate-limiting substrate in the biosynthesis of reduced GSH. Deprivation of cystine or Cys or inhibition of their membrane transporters (system Xc<sup>−</sup> cystine/glutamate antiporter) induces ferroptosis by depleting cellular GSH and increasing ROS (<xref ref-type="bibr" rid="bib43">Yang et al., 2022</xref>). Glutamine (Gln) metabolism is tightly linked to ferroptosis regulation. After influx into cells via SLC1A5 (ASCT2), Gln is converted to glutamate (Glu) to produce GSH, together with Cys and glycine (Gly), to maintain redox homeostasis (<xref ref-type="bibr" rid="bib17">Hensley et al., 2013</xref>). Collectively, these findings demonstrate that dysregulation of amino acid metabolism plays an important role in the regulation of ferroptosis (<xref ref-type="bibr" rid="bib20">Jiang et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Cormerais et al., 2020</xref>). It is anticipated that sodium-dependent neutral amino acid transporter-2 (<italic>Slc38a2</italic>), as a Cys, Glu, Gly, and methionine (Met) transporter and an osmoresponsive gene, may have a great impact on GPX4 activity and GSH biosynthesis (<xref ref-type="bibr" rid="bib27">Nahm et al., 2002</xref>; <xref ref-type="bibr" rid="bib25">Mackenzie and Erickson, 2004</xref>). However, whether SLC38A2 contributes to ferroptosis regulation in renal medullary cells under hyperosmotic stress has not been explored and warrants further investigation.</p><p>In the present study, we found that ferroptosis is the major RCD in IMCD cells exposed to hyperosmotic stress. Using RNA-Seq, we found that hyperosmolarity induced <italic>Slc38a2</italic> expression in IMCD cells in an NF-κB-dependent manner. Using <italic>Slc38a2</italic>-knockout mice and cultured IMCD cells, we further demonstrated that SLC38A2 exerted an osmoprotective effect on IMCD cells by inhibiting ferroptosis through activation of the SLC38A2-mTORC1 pathway. These findings uncover SLC38A2 as an osmoprotective amino acid transporter that protects renal MCD cells by inhibiting hyperosmolarity-induced ferroptosis via mTORC1 activation. <italic>Slc38a2</italic> is a critical osmoprotective gene in the renal medulla, which is a prerequisite for urine concentration and water homeostasis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Ferroptosis is the major type of regulated cell death in IMCD cells exposed to hyperosmolarity</title><p>Multiple types of RCD are involved in hyperosmolarity-induced cell damages, including apoptosis, necroptosis, and autophagy (<xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Nunes et al., 2013</xref>; <xref ref-type="bibr" rid="bib3">Bittner et al., 2017</xref>). We and others have previously reported that hyperosmotic stress significantly decreases renal medullary cell viability and induces apoptosis in only a small portion of the cell population (<xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Dmitrieva et al., 2000</xref>; <xref ref-type="bibr" rid="bib21">Küper et al., 2011</xref>), suggesting that other types of RCD may account for hyperosmolarity-elicited cell death. To characterise the exact RCD type responsible for hyperosmolarity-induced cell death and identify new mechanistic pathways involved in the osmoprotection of renal medullary cells, we treated mIMCD3 cell line with hyperosmotic medium for 12 h. As previously reported, hyperosmolarity significantly reduced cell viability. Ultrastructural analysis by transmission electron microscopy revealed that hyperosmolarity-treated mIMCD3 cells exhibited typical morphological features of ferroptosis, including shrunken mitochondria with disappeared and fragmented cristae and disrupted cell membranes, suggesting that ferroptosis is involved in hyperosmolarity-induced cell death (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). To prove this, we performed whole transcriptome analysis using RNA-Seq in mIMCD3 cells incubated under either isosmotic or hyperosmotic conditions and found that the expression of many genes associated with ferroptosis, including <italic>Slc7a11</italic>, <italic>Slc40a1</italic>, <italic>Gpx4</italic>, <italic>Acsl4</italic>, <italic>Vdac2</italic>, <italic>Tfrc</italic>, <italic>Ncoa4</italic>, and <italic>Slc3a2</italic>, was significantly altered after hyperosmotic treatment (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). To confirm the involvement of ferroptosis in hyperosmolarity-induced cell death, we pre-treated mIMCD3 cells with liproxstatin-1 (Lip-1), an inhibitor of ferroptosis, followed by hyperosmotic stress. The result showed that Lip-1 attenuated cell viability in a dose-dependent manner (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Cell viability was also improved in a dose-dependent manner by ferrostatin-1 (Fer-1), another ferroptosis inhibitor (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Lip-1 and Fer-1 at high doses almost completely abolished hyperosmolarity-induced cell death, suggesting that ferroptosis is the major type of RCD contributing to hyperosmotic stress-induced cell injury in IMCD cells (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). In support of this, a cytometry study showed that hyperosmolarity significantly increased cellular lipid ROS levels, which were completely suppressed by the ferroptosis inhibitors Lip-1 and Fer-1, indicating that hyperosmolarity promotes ferroptosis mainly by enhancing lipid peroxidation (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Conversely, the ferroptosis inducers, erastin and RSL-3, markedly increased the osmosensitivity of mIMCD3 cells in a dose-dependent manner (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). Consistently, both erastin and RSL3 aggravated hyperosmolarity-induced lipid ROS accumulation in IMCD cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). We also noticed that RSL3 caused a comparable degree of cell death and lipid ROS production between isosmolarity- and hyperosmolarity-treated mIMCD3 cells, suggesting that GPX4 activity is critical for the survival of mIMCD3 cells. Altogether, these findings demonstrate that ferroptosis is the major type of RCD in IMCD cells exposed to hyperosmolar stress.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Ferroptosis is the major type of regulated cell death in inner medullary collecting duct (IMCD) cells under hyperosmotic stress.</title><p>mIMCD3 cells were treated with various doses of the ferroptosis inhibitors and inducers for 24 h, with or without hyperosmotic exposure in the final 12 h. (<bold>A and B</bold>) The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay showing the ferroptosis inhibitor liproxstatin-1 (Lip-1) (<bold>A</bold>) and ferrostatin-1 (Fer-1) (<bold>B</bold>) increased the cell viability under hyperosmotic condition (600 mOsm) in a dose-dependent manner. n=4. (<bold>C</bold>) Flow cytometry assay showing that Lip-1 (1 μM) and Fer-1 (1 μM) completely abolished hyperosmolarity-elicited lipid reactive oxygen species (ROS) production. n=7. (<bold>D</bold>) The system Xc<sup>−</sup> inhibitor erastin worsened hyperosmolarity-induced mIMCD3 cell death in a dose-dependent manner. Note: Erastin slightly reduced the viability of mIMCD3 cells exposed to isosmolarity. n=4. (<bold>E</bold>) The GPX4 inhibitor RSL3 induced mIMCD3 cell death under either isosmotic or hyperosmotic conditions. A slight difference in cell viability was found between the two groups. n=4. (<bold>F</bold>) Flow cytometry analysis results showing that RSL3 caused comparable production of lipid ROS in mIMCD3 cells treated with isosmolarity or hyperosmolarity. Compared to erastin, RSL3 was more potent in promoting lipid ROS production. n=3. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A and B; one-way ANOVA tests for C and F; two-way ANOVA tests for D and E. See numerical source data in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Hyperosmolarity treatment leads to reduced cell viability and severe mitochondrial damage.</title><p>(<bold>A</bold>) mIMCD3 cells were treated with isosmotic (300 mOsm) or hyperosmotic (600 mOsm) medium for 12 h. MTT assay showed that cell viability was significantly reduced under hyperosmotic conditions. (<bold>B</bold>) Effect of hyperosmolarity on the mitochondrial ultrastructure of mIMCD3 cells as assessed by transmission electron microscopy. The yellow arrows indicate the mitochondria, and red arrows indicate the cell membrane. After hyperosmotic treatment (600 mOsm) for 12 h, the mitochondrial cristae disappeared and were fragmented, and most mitochondria became smaller and shrunk. A broken cell membrane was frequently evident. Scale bars = 5 μm (left panels) and 1 μm (right panels). n=12. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A. See numerical source data in <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig1-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Ferroptosis is involved in the hyperosmolality-induced cell death of inner medullary collecting duct cells.</title><p>We analysed the RNA-Seq results and found that the expression of many genes associated with the ferroptotic process was significantly altered after hyperosmotic treatment. The expression of <italic>Slc7a11</italic>, <italic>Slc40a1</italic>, <italic>Gpx4</italic>, <italic>Acsl4</italic>, <italic>Vdac2</italic>, <italic>Tfrc</italic>, and <italic>Ncoa4</italic> was significantly upregulated, whereas <italic>Slc3a2</italic> expression was downregulated under hyperosmotic conditions (n=4). <italic>Slc7a11</italic> and <italic>Slc3a2</italic> form system Xc<sup>−</sup>, which transports glutamate, a raw material for glutathione synthesis, into cells. <italic>Slc40a1</italic>, also named ferroportin 1 (<italic>Fpn1</italic>), is an iron transporter involved in iron export from cells and also contributes to transferring iron between maternal and foetal circulations. Transferrin (serum transferrin or lactoferrin) mediates iron uptake through the transferrin receptor (<italic>Tfrc</italic>), which promotes ferroptosis. <italic>Acsl4</italic> mediates the oxidation of polyunsaturated fatty acids, including arachidonic acid, which are required for the lipotoxicity of ferroptosis. Upregulation of <italic>Acsl4</italic> expression is a hallmark of ferroptosis. <italic>Vdac2</italic> is a voltage-dependent anion channel that transports ions and metabolites and is closely related to ferroptosis. Nuclear receptor coactivator 4 (<italic>Ncoa4</italic>) can result in the degradation of ferritin and a subsequent increase in the intracellular levels of ferrous iron, ultimately leading to ferroptosis. n=4. FPKM, fragments per kilobase of transcript sequence per million; ISO, isosmolarity; HYPER, hyperosmolarity. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for <bold>A–H</bold>. See numerical source data in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig1-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig1-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Slc38a2 is an osmoresponsive gene in cultured mIMCD3 cells</title><p>RNA-Seq analysis showed that 5197 genes were upregulated, and 4069 genes were downregulated after hyperosmotic treatment (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). Among these were numerous osmoresponsive genes, including <italic>Hspa1a</italic>, <italic>Hspa1b</italic>, <italic>Hspa41</italic>, <italic>Nfat5</italic> (<italic>TonEBP</italic>), and <italic>Hif1α</italic>, which have been previously reported to be induced by hyperosmolarity (<xref ref-type="bibr" rid="bib42">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib28">Neuhofer et al., 2004</xref>; <xref ref-type="fig" rid="fig2">Figure 2C</xref>). As the solute carrier (SLC) family plays an important role in the survival of renal IMCD cells under hyperosmolar conditions, we systemically analysed the mRNA levels of the <italic>Slc</italic> family and found that the expression of <italic>Slc38a2, Slco4a1</italic>, <italic>Slc5a3</italic>, <italic>Slc34a2</italic>, <italic>Slc45a3</italic>, <italic>Slc30a4</italic>, <italic>Slc15a3</italic>, <italic>Slc7a11</italic>, <italic>Slc6a6</italic>, and <italic>Slc16a10</italic> was significantly upregulated under hyperosmotic conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). As emerging evidence suggests that amino acids are important osmolytes in the regulation of osmoadaptive responses (<xref ref-type="bibr" rid="bib2">Bevilacqua et al., 2005</xref>; <xref ref-type="bibr" rid="bib18">Horio et al., 1997</xref>; <xref ref-type="bibr" rid="bib9">Dall’Asta et al., 1999</xref>), we further examined the presence of each <italic>Slc</italic> family member response for amino acid transport in the kidney using publicly available single-cell RNA-Seq databases (<ext-link ext-link-type="uri" xlink:href="https://www.bioparadigms.org/">https://www.bioparadigms.org/</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://cello.shinyapps.io/kidneycellexplorer/">https://cello.shinyapps.io/kidneycellexplorer/</ext-link>). The results showed that 51 amino acid transporters were expressed in mouse kidneys, where <italic>Slc38a2</italic> represents one of the major amino acid transporters with high medullary tubule expression (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). We further found that among the 51 amino acid transporters expressed in the kidney, <italic>Slc38a2</italic> is a member of the <italic>Slc38</italic> subfamily, with the highest expression level in cultured mIMCD3 cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>) and is the major member of the <italic>Slc38</italic> subfamily, whose expression was significantly induced by hyperosmolarity (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). As expected, <italic>Slc38a2</italic> was mainly expressed in the cell membrane and cytoplasm of 293T cells transfected with an expression vector, carrying an EGFP-fused full-length mouse <italic>Slc38a2</italic> cDNA sequence (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Collectively, these findings demonstrate that <italic>Slc38a2</italic> is a novel osmoresponsive gene in renal MCD cells.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RNA-Seq analysis identifies <italic>Slc38a2</italic> as an osmoregulated neutral amino acid transporter in mIMCD3 cells.</title><p>mIMCD3 cells were cultured under either isosmotic (300 mOsm) or hyperosmotic (600 mOsm) conditions for 6 h, and mRNA was then extracted for RNA-Seq analysis. (<bold>A</bold>) Venn diagram showing the overlap of different genes among the hyperosmotic and isosmotic groups. The co-expressed genes between the hyperosmotic and isosmotic groups are also shown. The sum of all the numbers in the circle of Venn diagram represents the total number of differential genes in the comparison combination, and the overlap area represents the number of common differential genes in the combination. (<bold>B</bold>) The volcano map visually displaying the differential gene distribution of the hyperosmotic and isosmotic groups. The abscissa in the figure represents the fold change of gene expression (log2FoldChange) in the groups, and the ordinate represents the significance level of the difference in gene expression between the treatment and control groups (−log10padj or −log10pvalue). Red dots represent the upregulated genes, and green dots indicate downregulated genes. The volcano map shows that 5197 genes were upregulated, and 4069 genes were downregulated after hyperosmotic treatment. (<bold>C</bold>) RNA-Seq analysis results showing that hyperosmolarity increased the mRNA levels of previously reported osmoregulatory genes. After hyperosmotic treatment, the expression of <italic>Hspa1a</italic>, <italic>Hspa1b</italic>, <italic>Hspa41</italic>, <italic>Nfat5</italic>, <italic>Gadd45b,</italic> and <italic>Hif1a</italic> was significantly increased. n=4. (<bold>D</bold>) RNA-Seq results demonstrating that hyperosmolarity significantly induced <italic>Slc38a2</italic> mRNA expression in mIMCD3 cells. A slight change in <italic>Slc38a1</italic>, <italic>Slc38a7,</italic> and <italic>Slc38a10</italic> expression was observed. n=4. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for <bold>C–D</bold>. See numerical source data in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>RNA-Seq analysis shows that hyperosmolarity induces <italic>Slc38a2</italic> mRNA expression in mIMCD3 cells.</title><p>(<bold>A</bold>) <italic>Slc</italic> members whose mRNA expression was induced by hyperosmolarity. Hyperosmotic stress significantly upregulated the mRNA expression of <italic>Slco4a1</italic>, <italic>Slc5a3</italic>, <italic>Slc38a2</italic>, <italic>Slc34a2</italic>, <italic>Slc45a3</italic>, <italic>Slc30a4</italic>, <italic>Slc15a3</italic>, <italic>Slc7a11</italic>, <italic>Slc6a6</italic>, and <italic>Slc16a10</italic>. n=4. (<bold>B</bold>) RNA-Seq results showing the mRNA abundance of each member of the <italic>Slc38</italic> subfamily in mIMCD3 cells under isosmotic conditions (300 mOsm). <italic>Slc38a2</italic> represents the most abundant member in the <italic>Slc38</italic> subfamily. n=4. (<bold>C</bold>) Gene heatmap of the <italic>Slc38</italic> family showing that <italic>Slc38a2</italic> was the major inducible member under hyperosmotic stress (600 mOsm). FPKM, fragments per kilobase of transcript sequence per million; ISO, isosmolarity; HYPER, hyperosmolarity. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A. See numerical source data in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Expression and distribution of amino acid transporters in the juxtamedullary and cortical nephron and renal collecting duct.</title><p>The heat map shows the gene expression of 51 amino acid transporters in epithelial cells along the nephron and collecting duct. The nephrons and collecting ducts were subdivided into 32 segments (cell types) (data from KidneyCellExplorer, <ext-link ext-link-type="uri" xlink:href="https://cello.shinyapps.io/kidneycellexplorer/">https://cello.shinyapps.io/kidneycellexplorer/</ext-link>; ). The numbers indicate the histological structure or cell type of the kidneys in both sexes as follows: (1) glomerular podocytes (visceral epithelium); (2) glomerular parietal epithelium; (3) segment 1 of the proximal tubule – female; (4) segment 1 of the proximal tubule – male; (5) segment 2 of the proximal tubule – female; (6) segment 2 of the proximal tubule – male; (7) segment 3 of the proximal tubule – female; (8) segment 3 of the proximal tubule – male; (9A) LOH, thin descending limb of the inner stripe of the outer medulla of the cortical nephron; (9B) LOH, thin descending limb of the inner stripe of the outer medulla of the juxtamedullary nephron; (10) upper LOH, thin descending limb of the inner medulla of the juxtamedullary nephron; (11) lower LOH, thin descending limb of the inner medulla of the juxtamedullary nephron; (12) lower LOH, thin limb of the inner medulla of the juxtamedullary nephron; (13) lower LOH, thin limb of the inner medulla of the juxtamedullary nephron; (14) upper LOH, thin ascending limb of the inner medulla of the juxtamedullary nephron; (15) distal straight tubule of the inner stripe of the outer medulla (syn: thick ascending limb of the LOH); (16) distal straight tubule of the outer stripe of the outer medulla and cortex (syn: thick ascending limb of LOH); (17) macula densa; (18) distal convoluted tubule; (19) nephron-connecting tubule; (20) principal-like cells of nephron-connecting tubules; (21) intercalated type non-A non-B cells of the nephron connecting tubule; (22) intercalated type A cells of the nephron connecting the tubule and the cortical collecting duct; (23) principal-like cell of the cortical collecting duct; (24) intercalated type B cells in the cortical collecting duct; (25) intercalated type A cells of the outer medullary collecting duct; (26) principal cell of the outer medullary collecting duct; (27) intercalated type A cells of the inner medullary collecting duct; (28) principal cell of the inner medullary collecting duct type 1; (29) principal cell of the inner medullary collecting duct type 2; (30) principal-like cells of the deep inner medullary collecting duct type 1; (31) cells of the deep inner medullary collecting duct type 2; and (32) deep medullary epithelium of the pelvis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>RNA-Seq analysis identifies <italic>Slc38a2</italic> as an osmoregulated amino acid transporter in mIMCD3 cells.</title><p>The 51 amino acid transporters in mIMCD3 cells were further screened and analysed using our RNA-Seq dataset. The heat map shows the expression changes of fragments per kilobase of transcript sequence per million (FPKM) values of 51 amino acid transporter genes under normal osmotic (300 mOsm) and hyperosmotic (600 mOsm) conditions. Among them, <italic>Slc38a2</italic> was the amino acid transporter most significantly induced by hyperosmolarity. ISO, isosmolarity; HYPER, hyperosmolarity.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>SLC38A2 protein is expressed in the cell membrane and cytoplasm.</title><p>The <italic>Slc38a2</italic>-C-EGFP plasmid was transfected into 293T cells. (<bold>A</bold>) Real-time PCR analysis results showing a marked increase in <italic>Slc38a2</italic> mRNA in the cells transfected with the <italic>Slc38a2</italic>-C-EGFP expression vector. n=3. (<bold>B</bold>) Western blotting analysis results demonstrating a significant increase in SLC38A2 protein expression in the cells transfected with the <italic>Slc38a2</italic>-C-EGFP expression vector. (<bold>C</bold>) Immunofluorescence analysis results showing that SLC38A2 was mainly expressed in the cell membrane and cytoplasm. The nucleus was stained blue with DAPI. The green colour represents EGFP fluorescence, indicating the subcellular location of SLC38A2. Immunofluorescence staining of Na<sup>+</sup>-K<sup>+</sup>-ATPase (red) indicates its location in the cell membrane. Scale bar = 5 μm. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A. DAPI, 4',6-diamidino-2-phenylindole. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig2s4sdata1">Figure 2—figure supplement 4—source data 1</xref>.</p><p><supplementary-material id="fig2s4sdata1"><label>Figure 2—figure supplement 4—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig2-figsupp4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig2-figsupp4-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Intrarenal localisation and osmoregulation of SLC38A2 in the mouse kidney</title><p>To study the physiological function of SLC38A2 in the kidney, we first determined the intrarenal localisation of SLC38A2 in the mouse kidney. We searched a single-cell RNA-Seq database (<ext-link ext-link-type="uri" xlink:href="https://cello.shinyapps.io/kidneycellexplorer/">https://cello.shinyapps.io/kidneycellexplorer/</ext-link>) of mouse kidneys and mapped their expression in the nephron. The results showed that <italic>Slc38a2</italic> mRNA was abundantly expressed in the medullary loop of Henle and MCD epithelial cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). To determine the intrarenal localisation of SLC38A2, an immunohistochemical assay was performed using an SLC38A2-specific antibody. We found that SLC38A2 protein was ubiquitously expressed in most renal tubule segments, with relatively higher levels in renal MCD epithelial cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These findings demonstrate that SLC38A2 is constitutively expressed in MCD epithelial cells. To determine whether SLC38A2 expression was upregulated under hyperosmotic conditions in vivo, C57BL/6 wild-type (WT) mice were deprived of water for 24 h, and the expression of <italic>Slc38a2</italic> mRNA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and protein (<xref ref-type="fig" rid="fig3">Figure 3C–D</xref>) was examined. The results showed that both <italic>Slc38a2</italic> mRNA and protein expression were significantly upregulated in renal medullas (<xref ref-type="fig" rid="fig3">Figure 3B–D</xref>), especially in renal MCD cells, as assessed by immunohistochemical analysis (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). These results are consistent with the in vitro findings and demonstrate that SLC38A2 is constitutively expressed in renal MCD cells, where its expression is significantly upregulated in the renal medulla of dehydrated mice.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Intrarenal localisation and osmoregulation of SLC38A2 protein in the kidney.</title><p>(<bold>A</bold>) Immunohistochemical analysis results indicating intrarenal localisation of SLC38A2 protein in mice. The results showed that SLC38A2 was expressed at relatively high level in the proximal tubule, thick ascending limb, and collecting duct, with low expression in the distal tubule. AQP1, THP, NCC, and AQP2 are markers for the proximal tubule, distal tubule, thick ascending limb, and collecting duct, respectively. (<bold>B–D</bold>) Water deprivation increased medullary <italic>Slc38a2</italic> mRNA (<bold>B</bold>) and protein (<bold>C</bold>) expression in mice. Male C57BL/6 mice were deprived of water for 24 h. Real-time PCR and western blotting analyses were used to measure <italic>Slc38a2</italic> mRNA and protein expression in renal medullas, respectively. SLC38A2 protein levels were semi-quantitated (<bold>D</bold>). B, n=6; D, n=3–5. (<bold>E</bold>) Immunohistochemical analysis results showing that SLC38A2 protein expression was induced in renal medullary collecting duct cells. Scale bar = 50 μm. WD, water deprivation. Data are means ± SEM. Two-tailed Student’s <italic>t</italic>-test for B and D. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Intrarenal localisation and osmoregulation of <italic>Slc38a2</italic> mRNA in the kidney.</title><p>(<bold>A</bold>) Single-cell sequencing results showing that <italic>Slc38a2</italic> mRNA was wildly expressed in the renal nephron epithelium, ureteric epithelium, vasculature, immune cells, and interstitial cells. (<bold>B</bold>) Segmental expression of <italic>Slc38a2</italic> in the cortical and juxtamedullary nephron and ureteric epithelium. <italic>Slc38a2</italic> was highly expressed in the ascending and descending branches of the loop of Henle and the collecting ducts. The nephron and collecting duct were subdivided into 32 segments as described in detail in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. Data were extracted from KidneyCellExplorer, <ext-link ext-link-type="uri" xlink:href="https://cello.shinyapps.io/kidneycellexplorer/">https://cello.shinyapps.io/kidneycellexplorer/</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title><italic>Slc38a2</italic> gene deficiency accelerates renal medullary cell ferroptosis in dehydrated mice</title><p>To study the role of SLC38A2 protein in the mouse kidney, we used CRISPR/Cas9 to generate a mouse deficient for <italic>Slc38a2</italic> on a C57BL/6 background (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). Owing to the high incidence of postnatal lethality in <italic>Slc38a2</italic>-knockout mice (<italic>Slc38a2<sup>−/−</sup></italic>) on a C57BL/6 background (<xref ref-type="bibr" rid="bib36">Weidenfeld et al., 2021</xref>), we crossed <italic>Slc38a2</italic> heterozygous mice with WT mice on a 129 background for five generations to obtain developmentally normal <italic>Slc38a2</italic>-knockout mice for in vivo studies. Using RT-PCR and western blotting assays, we validated the successful generation of <italic>Slc38a2<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>). To explore the role of SLC38A2 in the kidney, we collected 24 h urine samples from WT and <italic>Slc38a2<sup>−/−</sup></italic> mice and found that <italic>Slc38a2<sup>−/−</sup></italic> mice exhibited a polyuria phenotype (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>) and increased urine osmolyte excretion (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>). After 24 h water restriction, although no difference in urine output and osmolality was observed between the two genotypes, <italic>Slc38a2<sup>−/−</sup></italic> mice exhibited an increased urine volume to body weight ratio (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D–F</xref>). These results suggested that SLC38A2 may play an important role in the establishment of a medullary osmotic gradient and urine concentration. To determine whether <italic>Slc38a2</italic> gene deficiency is involved in ferroptosis in the renal medulla of water-deprived mice, we measured Fe<sup>2+</sup>, glutathione, and malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity in the renal medulla of both genotypes. The results showed that <italic>Slc38a2</italic> <sup>−/−</sup> mice exhibited a significant increase in Fe<sup>2+</sup> and MDA levels and a marked decrease in GSH and SOD concentrations (<xref ref-type="fig" rid="fig4">Figure 4D–I</xref>). Furthermore, immunohistochemical analysis revealed that <italic>Slc38a2<sup>−/−</sup></italic> mice exhibited much higher levels of 4-Hydroxynonenal (4-HNE, a well-studied aldehyde product of phospholipid peroxidation) and 8-oxodG (a product of DNA oxidative damage) in the renal medulla than WT mice (<xref ref-type="fig" rid="fig4">Figure 4J&amp;K</xref>). These findings suggest that <italic>Slc38a2</italic> deficiency is associated with increased iron-dependent lipid peroxidation, a hallmark of ferroptosis in the renal medulla of dehydrated mice. Consistent with the in vitro findings, under water deprivation, <italic>Slc38a2</italic> mice displayed more severe suppression of GPX4 levels and mTORC1 activity than WT mice (<xref ref-type="fig" rid="fig4">Figure 4L</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref>), suggesting that the renal medullary cells of <italic>Slc38a2</italic> <sup>−/−</sup> mice were more susceptible to hyperosmotic stress-induced cell injury. This speculation was further confirmed by the finding that water restriction resulted in a marked increase in cell death in the medulla of <italic>Slc38a2</italic> <sup>−/−</sup> mice as assessed by the TUNEL assay, with little change in caspase-3 expression and activity (<xref ref-type="fig" rid="fig4">Figure 4M–N</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B–C</xref>). Collectively, these findings demonstrate that global <italic>Slc38a2</italic> gene deficiency accelerates renal medullary cell ferroptosis in dehydrated mice with damaged urine concentration, suggesting that SLC38A2 expression in the renal collecting duct is critical in maintaining urine concentration capacity, mainly by protecting IMCD cells from ferroptosis under dehydration.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Slc38a2</italic>-gene deficiency accelerates renal medullary cell ferroptosis in dehydrated mice.</title><p>(<bold>A</bold>) Strategy for generating global <italic>Slc38a2</italic>-gene knockout mice using the CRISP/cas9 technique to delete a 10 bp of DNA sequence (5′-<named-content content-type="sequence">CCA CAA TCG C</named-content>-3′) in the fourth exon of the <italic>Slc38a2</italic> gene. (<bold>B and C</bold>) RT-PCR (<bold>B</bold>) and western blotting (<bold>C</bold>) assays showing the absence of Slc38a2 mRNA and protein in the kidney and liver of <italic>Slc38a2</italic><sup>−/−</sup> mice, respectively. (<bold>D</bold>) <italic>Slc38a2</italic><sup>−/−</sup> mice exhibited significantly increased renal medullary Fe<sup>2+</sup> concentration compared to wild-type mice after water deprivation. n=8. (<bold>E–G</bold>) Water deprivation resulted in a significant decrease in total (<bold>E</bold>) and reduced (<bold>F</bold>) GSH levels and GSH/GSSG ratios in the renal medulla of <italic>Slc38a2</italic>-KO mice. n=8. (<bold>H and I</bold>) Water deprivation resulted in a significant increase in MDA (<bold>H</bold>) and a marked reduction in SOD activity (<bold>I</bold>) in the medulla of <italic>Slc38a2</italic><sup>−/−</sup> mice. n=7–8. (<bold>J and K</bold>) Immunohistochemical analysis results showing that 4-HNE and 8-oxo-dG levels were significantly increased in the renal medulla of <italic>Slc38a2</italic><sup>−/−</sup> mice compared with that in wild-type mice after water deprivation. n=6. Scale bar = 50 μm. (<bold>L</bold>) Western blotting assay results demonstrating that water deprivation led to a significant decrease in the levels of total and phosphorylated S6 and 4EBP1 protein expression in the medulla of <italic>Slc38a2</italic><sup>−/−</sup> mice compared with that in wild-type mice. (<bold>M</bold>) Immunofluorescence analysis results showing that water restriction resulted in a marked increase in cell death (green) in the medulla of <italic>Slc38a2</italic><sup>−/−</sup> mice as assessed by the TUNEL assay. Scale bar = 25 μm. (<bold>N</bold>) Water restriction resulted in a marked increase in cell death in the medulla of the <italic>Slc38a2</italic><sup>−/−</sup> mice as assessed by the TUNEL assay. n=4. WT, wild-type; KO, <italic>Slc38a2</italic><sup>−/−</sup>; WD, water deprivation; GSH, reductive glutathione; GSSG, oxidised glutathione; MDA, malondialdehyde; SOD, superoxide dismutase. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for <bold>D, E, F, G, H, I, J, K, and N</bold>. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Generation and validation of global <italic>Slc38a2</italic>-gene knockout mice.</title><p>(<bold>A</bold>) Global <italic>Slc38a2-</italic>gene knockout mice were generated on C57BL/6 background by deleting a 10-bp sequence (5′-<named-content content-type="sequence">CCA CAA TCG C</named-content>-3′) in exon 4 using the CRISPR/Cas9 technique, followed by backcrossing to a 129 background for five generations. The genotype was confirmed by DNA sequencing. (<bold>B</bold>) Real-time PCR analysis results reveal extremely low <italic>Slc38a2</italic> mRNA levels in the liver and kidney of <italic>Slc38a2</italic><sup>−/−</sup> mice. n=3. WT, wild type; KO, knockout. See numerical source data in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig4-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Effect of <italic>Slc38a2</italic>-gene deficiency on urine output and osmolality in mice.</title><p>(<bold>A–C</bold>) <italic>Slc38a2<sup>−/−</sup></italic> mice exhibited increased urine volume and osmolality compared to wild-type mice. Male mice aged 8–10 wks were used. Urine volume, urine volume to body weight ratio, and urine osmolality were significantly increased in <italic>Slc38a2<sup>−/−</sup></italic> mice. n=6–8. (<bold>D–G</bold>) The effect of <italic>Slc38a2-</italic>gene deficiency on urine output and osmolality in mice subjected to water restriction for 24 h. WT, wild type; KO, knockout; WD, water deprivation. n=6–8. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for <bold>A–E</bold>. One-way ANOVA tests for F. See numerical source data in <xref ref-type="supplementary-material" rid="fig4s2sdata1">Figure 4—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig4-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Effect of water deprivation on mTORC1 activity and ferroptosis in the renal medulla of <italic>Slc38a2<sup>−/−</sup></italic> mice.</title><p>(<bold>A</bold>) Water deprivation led to a significant decrease in the levels of total and phosphorylated S6 and 4EBP1 protein expression in the medulla of <italic>Slc38a2<sup>−/−</sup></italic> mice. n=3. (<bold>B</bold>) The expression of total and cleaved caspase-3 expression in the renal medulla of wild-type and <italic>Slc38a2<sup>−/−</sup></italic> mice under water deprivation. No difference was observed between the two genotypes. (<bold>C</bold>) Caspase-3 activity in the renal medulla of wild-type and <italic>Slc38a2<sup>−/−</sup></italic> mice under water deprivation. No difference was observed between the two genotypes. n=7. WT, wild-type; KO, <italic>Slc38a2<sup>−/−</sup></italic>; WD, water deprivation. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for <bold>A and C</bold>. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig4s3sdata1">Figure 4—figure supplement 3—source data 1</xref>.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig4-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig4-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Hyperosmolarity induces SLC38A2 expression in cultured mIMCD3 cells and primary IMCD cells</title><p>To further confirm the induction of SLC38A2 by hyperosmotic stress, we determined the effect of hyperosmolarity on SLC38A2 expression at both the mRNA and protein levels in a cultured mouse IMCD cell line (mIMCD3 cells) (<xref ref-type="fig" rid="fig5">Figure 5</xref>) and mouse primary IMCD cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). In mIMCD3 cells, SLC38A2 expression was significantly induced by hyperosmolarity at both the mRNA and protein levels in a dose- (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>) and time-dependent manner (<xref ref-type="fig" rid="fig5">Figure 5D–G</xref>). We found that <italic>Slc38a2</italic> mRNA and protein expression reached their highest levels at 6 and 12 h after hyperosmotic exposure, respectively (<xref ref-type="fig" rid="fig5">Figure 5D–G</xref>). Immunofluorescence assay further showed that hyperosmolarity increased total SLC38A2 protein expression and its membrane translocation (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Similarly, in primary IMCD cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>), hyperosmolarity also induced <italic>Slc38a2</italic> mRNA and protein expression, as assessed using real-time PCR, western blotting, and immunofluorescence assays (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C–F</xref>). These findings demonstrate that hyperosmolarity induces SLC38A2 expression in renal collecting duct cells, which may contribute to the osmoadaptive response to medullary hyperosmotic stress.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Hyperosmolarity induces SLC38A2 expression in mIMCD3 cells.</title><p>(<bold>A</bold>) Real-time PCR assay showing that hyperosmolarity induced <italic>Slc38a2</italic> mRNA expression in mIMCD3 cells in a dose-dependent manner. The cells were incubated with hyperosmotic solutions (400–800 mOsm) for 6 h. n=6. (<bold>B–C</bold>) Western blotting analysis demonstrating that hyperosmolarity induced SLC38A2 protein expression in mIMCD3 cells in a dose-dependent manner. The cells were exposed to various degrees of hyperosmotic stress (400, 500, 600, 700, and 800 mOsm) for 12 h. SLC38A2 protein expression levels were quantitated (<bold>C</bold>). n=3. (<bold>D–E</bold>) Time-dependent effect of hyperosmolarity on <italic>Slc38a2</italic> mRNA expression. The cells were treated with a hyperosmotic solution (600 mOsm) at various time intervals. <italic>Slc38a2</italic> mRNA expression began to increase at 1.5 h (<bold>D</bold>) and reached the highest levels at 6 h after hyperosmolarity treatment (<bold>E</bold>). n=3–6. (<bold>F–G</bold>) Time-dependent induction of SLC38A2 protein expression by hyperosmolarity. SLC38A2 protein expression began to increase at 6 h (<bold>F</bold>) and reached the highest level at 12 h after the treatment (<bold>G</bold>). n=9. (<bold>H</bold>) Immunofluorescence studies showing that hyperosmolarity markedly induced SLC38A2 expression. DAPI stains the nucleus in blue. DID stains the cell membrane in red. SLC38A2 protein was stained in green. Scale bar = 5 μm. Data are means ± SEM; one-way ANOVA tests for A, C, D, E, and G. DAPI, 4',6-diamidino-2-phenylindole; DID, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine,4-chlorobenzenesulfonate salt. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Hyperosmolarity induces SLC38A2 expression in mouse primary inner medullary collecting duct (IMCD) cells.</title><p>(<bold>A</bold>) Morphological examination of mouse primary IMCD cells showing a typical oval shape under the light microscope. Scale bar = 50 μm. (<bold>B</bold>) Immunofluorescence analysis demonstrating the expression of aquaporin 2 (AQP2) protein (shown in green) on the cell membrane. The nucleus was visualised by staining with DAPI (blue). Scale bar = 25 μm. (<bold>C</bold>) Real-time PCR indicating hyperosmolarity-induced <italic>Slc38a2</italic> mRNA expression. Cultured primary IMCD cells were incubated with hyperosmotic solutions (900 mOsm) for 6 h. n=6. (<bold>D–E</bold>) Western blot assay showing that hyperosmolarity significantly induced SLC38A2 protein expression in IMCD cells. The IMCD cells were exposed to hyperosmotic stress (900 mOsm) for 12 h. n=3. (<bold>F</bold>) Immunofluorescence analysis showing that hyperosmolarity upregulated SLC38A2 expression and cell membrane translocation (red). The nucleus was visualised by staining with DAPI (blue). Scale bar = 25 μm. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for C and E. DAPI, 4',6-diamidino-2-phenylindole. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig5-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig5-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Hyperosmolarity induces SLC38A2 expression by activating the NF-κB pathway</title><p>To elucidate the molecular mechanism by which hyperosmolarity induces SLC38A2 expression, we determined the role of NF-κB in SLC38A2 expression in mIMCD3 cells under hyperosmotic stress. Hyperosmolarity treatment for 12 h increased p-NF-κB expression in a dose-dependent manner, but decreased p-IκBα expression (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), suggesting an induction of NF-κB activity by hyperosmolality. Immunofluorescence assay revealed that hyperosmolarity promoted the nuclear translocation of NF-κB in mIMCD3 cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Consistent with the in vitro findings, water deprivation for 24 h, which markedly increased renal medullary osmolality, significantly upregulated p-NF-κB protein levels and the ratios of p-NF-κB to total NF-κB in the renal medulla of WT C57BL/6 mice (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We further analysed the mouse <italic>Slc38a2</italic> gene promoter and found a potential NF-κB-binding site in the sequence between –867 nt and –876 nt (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Luciferase reporter assay showed that NF-κB promoted mouse <italic>Slc38a2</italic> gene promoter activity (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), and point mutation experiments further defined the sequence containing an NF-κB binding site (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Using a chromatin immunoprecipitation (ChIP) assay, we confirmed the binding of NF-κB to a sequence located in the <italic>Slc38a2</italic> promoter region (<xref ref-type="fig" rid="fig6">Figure 6F&amp;G</xref>). As expected, blockade of NF-κB activity by ammonium pyrrolidinedithiocarbamate, an NF-κB inhibitor, completely abolished hyperosmolarity-induced <italic>Slc38a2</italic> mRNA and protein expression (<xref ref-type="fig" rid="fig6">Figure 6H–J</xref>). Together, these findings demonstrate that the induction of SLC38A2 expression by hyperosmotic stress is dependent on the activation of the NF-κB signalling pathway.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Hyperosmolarity induces SLC38A2 expression by activating the nuclear factor kappa B (NF-κB) pathway.</title><p>(<bold>A</bold>) Hyperosmolarity increased NF-κB activity in mIMCD3 cells in a dose-dependent manner. mIMCD3 cells were treated with hyperosmotic solutions for 12 h. The protein levels of total and phosphorylated NF-κB and IκBα were measured by western blotting. (<bold>B</bold>) Immunofluorescence assay demonstrated that hyperosmolarity promoted nuclear translocation of NF-κB in mIMCD3 cells. The cells were exposed to hyperosmotic stress (600 mOsm) for 12 h. Scale bar = 8 μm. (<bold>C</bold>) Water deprivation significantly increased p-NF-κB protein levels and the ratio of p-NF-κB to total NF-κB in the renal medulla of WT C57BL/6 mice. The mice were subjected to water deprivation for 24 h or free access to water. (<bold>D</bold>) Luciferase reporter assay showed that NF-κB promoted mouse <italic>Slc38a2</italic> gene promoter activity. Three promoter fragments (−1435 bp~+124 bp, −961 bp~+124 bp, −473 bp~+124 bp) were obtained by PCR and subcloned into the pGL3-basic vector. n=4. (<bold>E</bold>) Point mutations defined a consensus sequence containing an NF-κB binding site in mouse <italic>Slc38a2</italic> gene promoter. A potential NF-κB binding site between −867 nt and −876 nt was predicted, and the sequence was mutated from 5′-<named-content content-type="sequence">GGG AAG GGC C</named-content>-3′ to 5′-<named-content content-type="sequence">TCA AGT CTC C</named-content>-3′. n=4. (<bold>F and G</bold>) Chromatin immunoprecipitation assay confirmed the binding of NF-κB to the <italic>Slc38a2</italic> promoter region. n=3. (<bold>H</bold>) Real-time PCR analysis showed that inhibition of NF-κB abolished hyperosmolarity-induced Slc38a2 mRNA expression. mIMCD3 cells were treated with the NF-κB inhibitor PDTC (10 μM) for 24 h, with hyperosmotic exposure for the last 12 h. n=3. (<bold>I and J</bold>) Western blots showed that inhibition of NF-κB blocked hyperosmolarity-induced SLC38A2 protein expression. n=4. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for D; one-way ANOVA tests for E, G, H, and J. Con, control mice with free access to water; WT, wild-type; KO, knockout; WD, water deprivation; PDTC, ammonium pyrrolidinedithiocarbamate. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig6-v2.tif"/></fig></sec><sec id="s2-7"><title>Overexpression of SLC38A2 protects mIMCD3 cells from hyperosmolarity-induced ferroptosis</title><p>To characterise the role of SLC38A2 in the survival of IMCD cells under hyperosmotic stress, we overexpressed SLC38A2 in mIMCD3 cells by infecting the cells with either an adenovirus expressing full-length <italic>Slc38a2</italic> (Ad-SLC38A2) or GFP (Ad-GFP) (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>), followed by hyperosmotic stress. Morphological examination and MTT assays showed that overexpression of SLC38A2 significantly attenuated hyperosmolarity-induced cell death (<xref ref-type="fig" rid="fig7">Figure 7C and D</xref>), suggesting that SLC38A2 protects mIMCD3 cells under hyperosmotic conditions. In addition, overexpression of SLC38A2 not only induced GPX4 expression in an isosmotic solution but also increased GPX4 expression under hyperosmotic stress (<xref ref-type="fig" rid="fig7">Figure 7E–F</xref>), indicating that SLC38A2 may exert anti-ferroptotic effects in IMCD3 cells by promoting GPX4 expression. To test this hypothesis, we treated Ad-SLC38A2-infected mIMCD3 cells with various doses of erastin and RSL3 and found that both ferroptosis inducers promoted ferroptosis in a dose-dependent manner under hyperosmolar conditions (<xref ref-type="fig" rid="fig7">Figure 7G–H</xref>). However, SLC38A2 overexpression abolished erastin-induced ferroptosis, with little effect on RSL3-elicited ferroptosis under hyperosmotic conditions (<xref ref-type="fig" rid="fig7">Figure 7G–H</xref>). Based on the capacity of SLC38A2 to transport amino acids for GSH biosynthesis, these findings suggested that SLC38A2 protects mIMCD3 cells from hyperosmolarity-induced ferroptosis, possibly by increasing intracellular GSH content and GPX4 activity.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Overexpression of SLC38A2 protects mIMCD3 cells from hyperosmolarity-induced ferroptosis.</title><p>(<bold>A and B</bold>) Adenovirus-mediated SLC38A2 overexpression at both the mRNA (<bold>A</bold>) and protein (<bold>B</bold>) levels. mIMCD3 cells were infected with the Ad-SLC38A2 or Ad-GFP (multiplicity of infection [MOI] = 20) for 24 h. Real-time PCR and western blot assays showed that Ad-SLC38A2 infection significantly increased <italic>Slc38a2</italic> mRNA (<bold>A</bold>) and protein (<bold>B</bold>) expression. n=6. (<bold>C</bold>) Morphological examination showing the protective effect of SLC38A2 overexpression on hyperosmolarity-induced mIMCD3 cell death. The cells were infected with Ad-SLC38A2 or Ad-GFP for 36 h (MOI = 20), followed by exposure to hyperosmotic stress (600 mOsm) for 12 h. Scale bar = 100 μm. (<bold>D</bold>) MTT assay demonstrating that SLC38A2 overexpression protects mIMCD3 cells from hyperosmolarity-induced cell death. n=5. (<bold>E and F</bold>) Western blotting analysis results showing that SLC38A2 overexpression increased GPX4 protein expression under both isosmotic and hyperosmotic conditions. The cells were treated as described in (<bold>C</bold>). n=4. (<bold>G</bold>) SLC38A2 protects erastin-induced ferroptosis of mIMCD3 cells under hyperosmotic stress. The cells were infected with Ad-SLC38A2 or Ad-GFP (MOI = 20) for 36 h, followed by treatment with erastin at various doses under hyperosmotic stress (600 mOsm) for 12 h. n=8. (<bold>H</bold>) The GPX4 inhibitor, RSL3, abolished the protective effect of SLC38A2 overexpression in hyperosmolarity-treated mIMCD3 cells. The cells were treated as described in (<bold>G</bold>). MTT assay was used to determine cell viability. RSL3 reduced cell viability in the hyperosmotic group to a greater extent than in the isosmotic group. n=3. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A; one-way ANOVA tests for D and F; two-way ANOVA tests for <bold>G and H</bold>. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig7-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig7-v2.tif"/></fig></sec><sec id="s2-8"><title>Inhibition and downregulation of SLC38A2 aggravate hyperosmolarity-induced ferroptosis in IMCD cells</title><p>To further confirm the anti-ferroptotic effect of SLC38A2 in IMCD cells, we treated mIMCD3 cells with 2-(methylamino) isobutyric acid (MeAIB), a competitive inhibitor of System A transporters, including SLC38A2, under isosmotic and hyperosmotic conditions. MTT assay showed that MeAIB treatment promoted cell death under both isosmotic and hyperosmotic conditions (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Conversely, knockdown of SLC38A2 expression in mIMCD3 cells (<xref ref-type="fig" rid="fig8">Figure 8B</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>) and knockout of SLC38A2 in primary IMCD cells (<xref ref-type="fig" rid="fig8">Figure 8C&amp;D</xref>) predisposed the cells to hyperosmolarity-induced ferroptosis. In addition, western blotting analysis showed that under hyperosmotic conditions (900 and 1200 mOsm), <italic>Slc38a2</italic>-gene deficient cells exhibited more robust suppression of GPX4 protein expression than WT control cells (<xref ref-type="fig" rid="fig8">Figure 8E–F</xref>), further suggesting that SLC38A2 ameliorates ferroptosis by increasing GPX4 protein expression. In support of this, Ad-SLC38A2 infection conferred cytoprotection against hyperosmolarity-induced cell death in both WT and <italic>Slc38a2</italic> gene-deficient primary IMCD cells (<xref ref-type="fig" rid="fig8">Figure 8G</xref>). These findings demonstrate that inhibition of SLC38A2 aggravates IMCD cell death, whereas overexpression of SLC38A2 reduces IMCD cell death under hyperosmotic conditions. In addition, the protective effect of SLC38A2 in IMCD cells was abolished by the GPX4 inhibitor RSL3 and partially attenuated by system Xc<sup>−</sup> (<xref ref-type="fig" rid="fig8">Figure 8H–I</xref>). Moreover, MeAIB, an SLC38A2 inhibitor, sensitised mIMCD3 cells to erastin-induced ferroptosis under hyperosmolar conditions (<xref ref-type="fig" rid="fig8">Figure 8J</xref>). These results further support the conclusion that the protective effect of SLC38A2 against hyperosmolarity-induced cell death is largely dependent on its anti-ferroptosis action by increasing GPX4 activity.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Inhibition or downregulation of SLC38A2 aggravates hyperosmolarity-induced ferroptosis in mIMCD3 and primary medullary collecting duct (MCD) cells.</title><p>(<bold>A</bold>) The System A amino acid transporter inhibitor 2-(methylamino) isobutyric acid (MeAIB) worsened hyperosmolarity-induced cell death. mIMCD3 cells were treated with 5 mM MeAIB for 24 h, with or without hyperosmotic exposure (600 mOsm) in the final 12 h. MTT assay was used to determine cell viability. n=12. (<bold>B</bold>) SLC38A2 knockdown sensitised mIMCD3 cells to hyperosmolarity-elicited cell death. The cells were transfected with <italic>Slc38a2</italic> small interfering RNA (siRNA) for 24 h, followed by exposure to hyperosmotic stress (600 mOsm) for 12 h. n=3. (<bold>C</bold>) <italic>Slc38a2</italic>-gene deficiency promoted hyperosmolarity-induced cell death. The primary inner MCD (IMCD) cells of the wild-type (<italic>Slc38a2<sup>+/+</sup></italic>, WT) and knockout (<italic>Slc38a2<sup>−/−</sup></italic>, KO) mice were challenged with hyperosmotic stress (900 mOsm) for 12 h. The cell numbers were examined by light microscopy. Scale bar = 100 μm. (<bold>D</bold>) MTT assay of primary MCD cells of WT and KO mice. The cells were treated with hypertonicity (900 mOsm) for 12 h. n=3. (<bold>E and F</bold>) Western blotting analysis results showing that hyperosmolarity caused a more significant decrease in GPX4 levels in SLC38A2<sup>−/−</sup> IMCD cells than in SLC38A2<sup>+/+</sup> IMCD cells under hyperosmotic conditions. n=5. (<bold>G</bold>) MTT experiment results demonstrating that adenovirus-mediated SLC38A2 overexpression completely reversed hyperosmotic stress-induced cell injury of primary SLC38A2<sup>−/−</sup> IMCD cells. n=3. (<bold>H</bold>) The System Xc<sup>-</sup> inhibitor erastin sensitised hyperosmolality-induced ferroptosis in SLC38A2<sup>−/−</sup> IMCD cells in a dose-dependent manner. Erastin also enhanced hyperosmotic stress-elicited ferroptosis in SLC38A2<sup>+/+</sup> IMCD cells to a lower extent than that in SLC38A2<sup>−/−</sup> MCD cells. n=3. (<bold>I</bold>) The GXP4 inhibitor RSL3 abolished the difference in cell viability under hyperosmotic stress between primary SLC38A2<sup>+/+</sup> and SLC38A2<sup>−/−</sup> IMCD cells in a dose-dependent manner. n=3. (<bold>J</bold>) MTT assay results demonstrating that the SLC38A2 blocker MeAIB sensitised mIMCD3 cells to erastin-induced ferroptosis under hyperosmolarity. mIMCD3 cells were treated with MeAIB at various doses for 24 h, with or without erastin (10 μM) treatment in the presence or absence of hyperosmolarity (600 mOsm) for the last 12 h. n=4. siNC, scramble siRNA control. Data are means ± SEM; one-way ANOVA tests for A, B, D, F, and G; two-way ANOVA tests for H, I, and J. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig8-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Knockdown of <italic>Slc38a2</italic> expression in mIMCD3 cells using a small interfering RNA (siRNA)-mediated approach.</title><p>(<bold>A</bold>) mIMCD3 cells were transfected with an <italic>Slc38a2</italic> siRNA. <italic>Slc38a2</italic> mRNA expression was significantly decreased by <italic>Slc38a2</italic> siRNA. (<bold>B</bold>) SLC38A2 protein expression was decreased after transfection with <italic>Slc38a2</italic> siRNA. n=3. siNC, scramble siRNA control. Data are means ± SEM; two-tailed Student’s <italic>t</italic>-test for A. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig8s1sdata1">Figure 8—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig8-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig8-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-9"><title>SLC38A2 protects IMCD cells from hyperosmotic stress-induced ferroptosis by activating mTORC1</title><p>SLC38A2-transported amino acids have been reported to activate the mTORC1 signalling pathway to promote cell growth <xref ref-type="bibr" rid="bib8">Cormerais et al., 2020</xref>. To test whether mTORC1 contributes to the SLC38A2-mediated protection of IMCD cells under hyperosmotic stress, we determined the effect of hyperosmolarity on mTORC1 activity. We found that hyperosmolality suppressed the total and phosphorylated levels of rpS6 and 4EBP1, two downstream effectors of mTORC1, in mIMCD3 cells in a dose-dependent manner (<xref ref-type="fig" rid="fig9">Figure 9A</xref>, <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A</xref>), suggesting that suppressed mTORC1 activity may be associated with reduced cell viability in IMCD cells exposed to hyperosmolarity. In support of this, inhibition of mTORC1 by rapamycin and torin-1 sensitised mIMCD3 cells to hyperosmotic stress-induced cell death in the presence of the ferroptosis inducer erastin (<xref ref-type="fig" rid="fig9">Figure 9B&amp;C</xref>). Although rapamycin and torin-1 treatments increased GPX4 protein expression under hyperosmotic conditions (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1B and C</xref>), mTORC1 inhibition by both compounds resulted in a significant decrease in GPx activity (<xref ref-type="fig" rid="fig9">Figure 9D</xref>) and a marked increase in cellular lipid ROS levels (<xref ref-type="fig" rid="fig9">Figure 9E</xref>). The induction of GPX4 protein expression by rapamycin and torin-1 may reflect positive feedback regulation of reduced GPX4 activity. Collectively, these results indicate that mTORC1 attenuates ferroptosis by maintaining intracellular GPX4 activity and blocking lipid peroxidation.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>SLC38A2 protects mIMCD3 cells from ferroptosis under hyperosmotic stress by activating mTORC1.</title><p>(<bold>A</bold>) Inhibitory effect of hyperosmolarity on the mTORC1 signalling pathway. mIMCD3 cells were incubated with hyperosmotic solutions for 12 h. Western blotting analysis showed that hyperosmolarity suppressed the total and phosphorylated S6 and 4E-BP1 expression in a dose-dependent manner. (<bold>B and C</bold>) MTT assay results showing that rapamycin (<bold>B</bold>) or torin-1 (<bold>C</bold>) sensitised mIMCD3 cells to erastin-induced ferroptosis under hyperosmolality. mIMCD3 cells were treated with rapamycin or torin-1 at various doses for 24 h. During the last 12 h, the cells were treated with or without erastin (10 μM) in the presence or absence of hyperosmolarity (600 mOsm). n=8. (<bold>D</bold>) The mTORC1 inhibitors, rapamycin and torin-1, reduced the activity of glutathione peroxidase (GPx) activity. The cells were treated with rapamycin (10 nM) or torin-1 (10 nM) for 24 h, with or without hyperosmotic treatment in the final 12 h. n=6. (<bold>E</bold>) Cytometry assay showing that rapamycin and torin-1 significantly increased the levels of lipid reactive oxygen species (ROS). n=3. (<bold>F</bold>) Western blotting assay results demonstrating that SLC38A2 overexpression reversed hyperosmolarity-suppressed expression of total and phosphorylated S6 and 4E-BP1. The cells were infected with Ad-SLC38A2 or Ad-GFP for 36 h followed by hyperosmotic stress for 12 h. (<bold>G–H</bold>) MTT assay results showing that rapamycin (<bold>G</bold>) and torin-1 (<bold>H</bold>) completely abolished the protective effect of SLC38A2 in mIMCD3 cells under hyperosmolarity. After being infected with the adenoviruses, the cells were treated with rapamycin (10 nM) or torin-1 (10 nM) for 24 h with or without hyperosmolarity in the last 12 h. n=9–12. Data are means ± SEM; two-way ANOVA tests for B and C; one-way ANOVA tests for D, E, G, and H. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig9">Figure 9</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig9-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>SLC38A2 protects mIMCD3 cells from ferroptosis under hyperosmotic stress by activating mTORC1.</title><p>(<bold>A</bold>) The effect of hyperosmolarity on the expression of mTORC1 downstream effector S6 and 4EBP1. The total and phosphorylated S6 and 4EBP1 expression were inhibited by hyperosmolarity in a dose-dependent manner. n=4. (<bold>B and C</bold>) Effect of the mTORC1 inhibitors, rapamycin and torin-1, on glutathione peroxidase 4 (GPX4) and SLC38A2 expression in mIMCD3 cells under isosmotic and hyperosmotic conditions. mIMCD3 cells were treated with rapamycin (10 nM) or torin-1 (10 nM) for 24 h, with exposure to isosmotic or hyperosmotic conditions during the final 12 h. The results showed that under hyperosmotic conditions, rapamycin and torin-1 treatment increased GPX4 expression, with little effect on SLC38A2 expression. The induction of GPX4 by rapamycin and torin-1 may reflect a positive feedback regulation of reduced GPX4 activity. n=5. (<bold>D</bold>) Adenovirus-mediated SLC38A2 overexpression reversed hyperosmolarity-induced suppression of the mTORC1 downstream effector S6 and 4EBP1. n=4. Data are means ± SEM; one-way ANOVA tests for A, C, and D. DMSO, dimethyl sulfoxide. See numerical source data and uncropped western blot images in <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig9s1sdata1"><label>Figure 9—figure supplement 1—source data 1.</label><caption><title>Numerical and uncropped western blot source data for <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80647-fig9-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig9-figsupp1-v2.tif"/></fig></fig-group><p>Furthermore, we found that adenovirus-mediated SLC38A2 overexpression completely abolished the hyperosmolarity-induced suppression of total and phosphorylated rpS6 and 4EBP1 protein levels (<xref ref-type="fig" rid="fig9">Figure 9F</xref>, <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1D</xref>), suggesting that SLC38A2 protects IMCD cells from ferroptosis by activating mTORC1. In support of this, the protective effect of SLC38A2 on hyperosmolarity-induced cell death was completely diminished by the inhibition of mTORC1 (<xref ref-type="fig" rid="fig9">Figure 9G–H</xref>). This result indicates that, in addition to system Xc<sup>−</sup>, SLC38A2 represents another important amino acid transporter that transports amino acids into cells to maintain the cellular glutathione level, thereby blocking ferroptosis. Collectively, our findings demonstrate that SLC38A2 protects IMCD cells from hyperosmotic stress-induced ferroptosis by activating mTORC1.</p></sec><sec id="s2-10"><title>Proposed model of SLC38A2 in the regulation of cell ferroptosis in renal MCDs under hyperosmotic stress</title><p>We present a schematic (<xref ref-type="fig" rid="fig10">Figure 10</xref>) showing the underlying mechanism by which SLC38A2 promotes the survival of renal MCD cells under hyperosmotic stress by inhibiting ferroptosis. (1) Hyperosmotic stress increases lipid ROS production, which promotes ferroptosis of MCD cells; (2) hyperosmolarity upregulates <italic>Slc38a2</italic> mRNA expression by activating the NF-κB pathway; (3) SLC38A2 mediates the uptake of Cys, Gly, and Gln, which may help maintain cellular redox homeostasis and intracellular GPX4 activity to exert its anti-ferroptotic effect; (4) SLC38A2-mediated uptake of glutamine can strongly activate mTORC1 by facilitating cellular uptake of leucine via the System L amino acid transporter LAT1; (5) SLC38A2 promotes Gln uptake, which is converted into α-ketoglutarate to activate mTORC1. Note: Erastin treatment decreases System Xc<sup>-</sup>, resulting in the reduction of Cys uptake and depletion of GSH, leading to a decrease in GPX4 enzymatic activity and an increase in lipid peroxidation. RSL3 blocks GPX4 activity, which decreases the cellular antioxidant capacity, leading to the accumulation of lipid ROS and ferroptosis. Liproxstatin-1 (Lip-1) and ferrostatin-1 (Fer-1) exert anti-ferroptotic effects by attenuating lipid peroxidation.</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Schematic showing the underlying mechanism by which SLC38A2 promotes the survival of renal medullary collecting duct (MCD) cells under hyperosmotic stress by inhibiting ferroptosis.</title><p>(1) Hyperosmotic stress increases lipid reactive oxygen species (ROS) production, which promotes ferroptosis of MCD cells; (2) hyperosmolarity upregulates <italic>Slc38a2</italic> mRNA expression by activating the nuclear factor kappa B (NF-κB) pathway; (3) SLC38A2 mediates the uptake of Cys, Gly, and Gln, which may help maintain cellular redox homeostasis and intracellular glutathione peroxidase 4 (GPX4) activity to exert its anti-ferroptotic effect; (4) SLC38A2-mediated uptake of glutamine can strongly activate mTORC1 by facilitating cellular uptake of leucine via the System L amino acid transporter LAT1; (5) SLC38A2 promotes Gln uptake, which is converted into α-ketoglutarate (α-KG) to activate mTORC1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-fig10-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The hyperosmotic state of the renal medulla is essential for urine concentration. However, the underlying mechanism by which renal MCD cells survive harsh hyperosmotic stress remains incompletely understood. The present study demonstrated a critical role for the sodium-dependent neutral amino acid transporter SLC38A2 in the survival of MCD cells under hyperosmolar conditions. First, we clarified that ferroptosis is a major type of RCD in IMCD cells under hyperosmotic stress. Second, we identified SLC38A2 as a previously uncharacterised osmoresponsive amino acid transporter in the kidney, where its expression is significantly induced by hyperosmolality. Third, we provided a compelling evidence that SLC38A2 plays an important role in protecting IMCD cells from hyperosmotic stress-induced ferroptosis, mainly by activating the mTORC1 signalling pathway. Finally, using <italic>Slc38a2-</italic> knockout mice, we confirmed the critical role of SLC38A2 in maintaining renal medullary homeostasis and renal urine concentration by attenuating medullary cell ferroptosis. Collectively, our findings demonstrate that <italic>Slc38a2</italic> is a critical osmoprotective gene in the renal medulla, and its appropriate function is a prerequisite for urine concentration.</p><p>MCD cells are essential for urine concentration and must adapt to constant changes in environmental osmolarity to maintain their viability and functionality (<xref ref-type="bibr" rid="bib37">Woo and Kwon, 2002</xref>; <xref ref-type="bibr" rid="bib12">Dmitrieva and Burg, 2005</xref>). However, the underlying mechanism by which MCD cells survive in harsh hyperosmotic environments remains unclear. In the past decade, it has been repeatedly reported that apoptosis is involved in hyperosmolarity-induced cell death in MCD cells, particularly IMCD cells, and multiple factors including TonEBP, NF-κB, P53, PPARβ/δ, and FXR protect MCD cell viability through their anti-apoptotic properties (<xref ref-type="bibr" rid="bib15">Han et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Guan, 2004</xref>; <xref ref-type="bibr" rid="bib11">Dmitrieva et al., 2001</xref>). However, emerging evidence suggests that in addition to apoptosis, other types of RCD may also contribute to hyperosmolarity-elicited death of MCD cells, as apoptotic cells only account for a small portion of the injured cell population (<xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Zhang et al., 2014</xref>). The present study provides a compelling evidence that ferroptosis represents the major type of RCD in hyperosmolarity-induced cell death, as the ferroptosis inhibitors, liproxstatin-1 and ferrostatin-1, almost completely abolish, whereas the ferroptosis inducers, erastin and RSL-3, significantly increase, hyperosmotic stress-induced injury of MCD cells.</p><p>The present study identified <italic>Slc38a2</italic> as an osmoresponsive gene in MCD cells. RNA-Seq analysis revealed 9266 genes differentially expressed in hyperosmolarity-treated mIMCD3 cells, including many previously reported osmoregulatory genes, such as <italic>Hspa1a</italic>, <italic>Hspa1b</italic>, <italic>Hspa41</italic>, <italic>Nfat5</italic> (<italic>TonEBP</italic>), and <italic>Hif1α</italic> (<xref ref-type="bibr" rid="bib42">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib38">Woo et al., 2002</xref>). In addition, an array of genes involved in amino acid transport was induced by hyperosmolar treatment. Among the amino acid transporters expressed in the mouse kidney, SLC38A2 is the major transporter in the SLC38 subfamily, with high abundance in renal MCD cells, where its expression is significantly induced by hyperosmolarity. In the present study, we also provide clear evidence that SLC38A2 is directly regulated by NF-κB, which can drive transcription of the <italic>Slc38a2</italic> gene by binding to its gene promoter. Therefore, <italic>Slc38a2</italic> is a novel osmoresponsive gene in IMCD cells, and its expression is under the direct control of NF-κB during hyperosmotic conditions.</p><p>SLC38A2 can transport a group of neutral amino acids, including cysteine, glutamine, glycine, alanine, asparagine, histidine, methionine, proline, and serine (<xref ref-type="bibr" rid="bib25">Mackenzie and Erickson, 2004</xref>; <xref ref-type="bibr" rid="bib34">Shen et al., 2022</xref>). It has been previously reported that an increase in intracellular glutamine, a common transport substrate for SLC38A2, is related to cell volume recovery under hyperosmotic conditions (<xref ref-type="bibr" rid="bib13">Franchi-Gazzola et al., 2006</xref>). During hyperosmotic conditions, System A transport activity increases in renal epithelial cells, tissue fibroblasts, vascular smooth muscle cells, lymphocytes, and endothelial cells (<xref ref-type="bibr" rid="bib13">Franchi-Gazzola et al., 2006</xref>; <xref ref-type="bibr" rid="bib5">Chen and Kempson, 1995</xref>; <xref ref-type="bibr" rid="bib40">Yamauchi et al., 1994</xref>; <xref ref-type="bibr" rid="bib35">Trama et al., 2002</xref>; <xref ref-type="bibr" rid="bib32">Petronini et al., 2000</xref>). The application of <italic>Slc38a2</italic> small interfering RNA (siRNA) to inhibit its expression can hinder the increase in intracellular amino acid content and delay the recovery of cell volume (<xref ref-type="bibr" rid="bib2">Bevilacqua et al., 2005</xref>). Therefore, SLC38A2 plays an important role in the regulation of cell volume upon hyperosmotic exposure, and the amino acids transported by SLC38A2 act as organic osmolytes in hyperosmotically stressed cells (<xref ref-type="bibr" rid="bib13">Franchi-Gazzola et al., 2006</xref>). In addition, emerging evidence shows that SLC38A2 can also transport betaine (<xref ref-type="bibr" rid="bib30">Nishimura et al., 2014</xref>), an important osmolyte contributing to the osmoprotection of the MCD cells of dehydrated animals. Therefore, the induction of SLC38A2 in hyperosmotically stressed cells and in the renal medulla of dehydrated mice may help restore cell volume and maintain cell viability and function of MCD cells.</p><p>In the present study, we report, for the first time, a critical role of SLC38A2 in protecting IMCD cells against hyperosmolarity-induced ferroptosis by increasing cellular antioxidant capacity. Unrestrained lipid peroxidation is a hallmark of ferroptosis (<xref ref-type="bibr" rid="bib6">Chen et al., 2021</xref>). The reduction of lipid peroxidation is essential for cell survival and requires functional GPX4 and GSH (<xref ref-type="bibr" rid="bib20">Jiang et al., 2021</xref>). Cys is the rate-limiting substrate in the biosynthesis of reduced GSH. Intracellular Cys and GSH levels are highly dependent on the system Xc<sup>−</sup> cystine/glutamate antiporter (<xref ref-type="bibr" rid="bib43">Yang et al., 2022</xref>). In addition, Glu, which can be converted from Gln and Met and metabolised into Cys and Gly, is also important for producing GSH to reduce lipid peroxidation via GPX4 (<xref ref-type="bibr" rid="bib17">Hensley et al., 2013</xref>). Therefore, SLC38A2, as a Cys, Gln, Met, and Gly transporter whose expression is abundantly present in IMCD cells and significantly induced by hyperosmolarity, may help maintain cellular redox homeostasis and intracellular GPX4 activity to exert its anti-ferroptotic effect in IMCD cells both in vitro and in vivo (<xref ref-type="fig" rid="fig10">Figure 10</xref>). In addition, we found that hyperosmotic stress reduced GPX4 levels in cultured IMCD cells, which could be restored by SLC38A2 overexpression. Conversely, water deprivation downregulated GPX4 expression in the renal medulla of WT mice, which was further reduced in <italic>Slc38a2<sup>−/−</sup></italic> mice. These findings demonstrate that SLC38A2 may protect MCD cells from ferroptosis by increasing GPX4 expression and activity.</p><p>In addition to supplying sufficient Cys, Glu, Met, and Gly for GSH biosynthesis in IMCD cells under hyperosmotic stress, SLC38A2 may also exert its anti-ferroptotic effect by activating the mTORC1 signalling pathway. mTORC1 integrates multiple signal inputs, including energy, growth factors, and amino acids, to promote cell growth and proliferation by phosphorylating S6K1 and 4EBP1 (<xref ref-type="bibr" rid="bib45">Zhang et al., 2021</xref>). In the present study, we found that hyperosmolarity suppressed IMCD cell viability by inhibiting mTORC1 activity, which was markedly attenuated by SLC38A2 overexpression. It has been previously reported that glutamine, a well-documented SLC38A2 substrate, can strongly activate mTORC1 by facilitating cellular uptake of leucine via the System L amino acid transporter SLC7A5/SLC3A2 (<xref ref-type="bibr" rid="bib29">Nicklin et al., 2009</xref>; <xref ref-type="bibr" rid="bib7">Cohen and Hall, 2009</xref>; <xref ref-type="fig" rid="fig10">Figure 10</xref>). Therefore, it is reasonable to draw a conclusion that hyperosmolarity-induced SLC38A2 expression may protect the MCDs of dehydrated mice through increasing mTORC1 expression and activity.</p><p>In the present study, we found that the <italic>Slc38a2-</italic>knockout mice exhibited a slight increase in both urine output and osmolyte excretion. It is speculated that as an amino acid transporter, <italic>Slc38a2</italic>-gene deficiency results in blunted cellular uptake of certain amino acids by peripheral tissues and elevated levels of amino acids in the plasma, which cause mild osmotic diuresis. Under dehydrated conditions, enhanced collecting duct ferroptosis may also contribute to increased urine output in the <italic>Slc38a2</italic>-knockout mice. In addition, elevated circulating amino acid levels and increased glomerular filtration of amino acids into the renal tubules may be responsible for a slight increase in urinary osmolarity observed in the <italic>Slc38a2</italic>-knockout mice.</p><p>Taken together, our data demonstrate that (1) ferroptosis is the major type of RCD in hyperosmolarity-exposed IMCD cells; (2) <italic>Slc38a2</italic> is a novel osmoresponsive gene in IMCD cells, and its expression is significantly induced by NF-κB under hyperosmotic stress; (3) SLC38A2 protects IMCD cells from hyperosmolality-induced ferroptosis both in vitro and in vivo; and (4) the renoprotective effect of SLC38A2 is mediated by the activation of the mTORC1 signalling pathway. Altogether, our study demonstrates that SLC38A2-mediated anti-ferroptotic effects represent a novel and critical mechanism by which renal MCD cells can survive and function in a harsh hyperosmotic environment. Pharmacological blockade of the SLC38A2-mTORC1 axis by the SLC38A2 inhibitor and rapamycin may disrupt renal medullary architecture and impair urine concentration by promoting ferroptosis of MCD cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animal studies</title><p>Male C57BL/6 WT mice were purchased from the Vital River Laboratory Animal Technology (Beijing, China). Global <italic>Slc38a2</italic>-knockout (<italic>Slc38a2<sup>−/−</sup></italic>) mice were generated on a C57BL/6 background by deleting a 10-bp sequence (5′-CCA CAA TCG C-3′) in exon 4 using the CRISPR/Cas9 technique. Owing to the high incidence of postnatal lethality in <italic>Slc38a2</italic>-knockout mice (<italic>Slc38a2<sup>−/−</sup></italic>) on a C57BL/6 background (<xref ref-type="bibr" rid="bib36">Weidenfeld et al., 2021</xref>), we crossed <italic>Slc38a2</italic> heterozygous mice with WT mice on a 129 background for five generations to obtain developmentally normal <italic>Slc38a2</italic>-knockout mice for in vivo studies. The genotype was confirmed by DNA sequencing (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Male mice aged 8–10 weeks were used in this study. All animals had free access to food and were either allowed free access to water or subjected to water restriction for 24 h. After water restriction, the mice were sacrificed and perfused with cold PBS. The left kidneys were fixed and paraffin-embedded, whereas the right kidneys were used to dissect the renal cortex and medulla.</p></sec><sec id="s4-2"><title>Chemicals and reagents</title><p>α-MeAIB was purchased from Sigma-Aldrich (Cat#M2383). Erastin (Cat#B1524), (1 S,3R)-RSL3 (Cat#B6095), liproxstatin-1 (Cat#B4987), and ferrostatin-1 (Cat#A4371) were purchased from Applied Biosystems. Torin-1 (Cat#4858) and rapamycin (Cat#9904) were purchased from Cell Signalling Technology. Antibodies against NF-κB (Cat#8242), p-NF-κB (Ser<sup>536</sup>, Cat#3033), IκBα (Cat#9242), p-IκBα (Ser (<xref ref-type="bibr" rid="bib44">Zhang et al., 2014</xref>), Cat#2859), rpS6 (Cat#2217), p-S6 (Ser<sup>235/236</sup>, Cat#4858), 4E-BP1 (Cat#9644), p-4E-BP1 (Thr<sup>37/46</sup>, Cat#2855), GPX4 (Cat#52455), caspase-3 (Cat#9662), and cleaved caspase-3 (Cat#9664) were purchased from Cell Signalling Technology. Antibodies against 4-HNE (Cat#MAB3249) and 8-oxo-dG (Cat#4354-MC-050) were purchased from R&amp;D Systems (Minneapolis, MN, USA). Primary antibodies against AQP1 (Cat#sc25287) and THP (Cat#sc271022) were purchased from Santa Cruz Biotechnology, and antibodies against NCC (Cat#ab95302) and AQP2 (Cat#ab199975) were purchased from Abcam. Primary antibodies against β-actin (Cat. #60008–1-Ig) were purchased from Proteintech. An antibody against SLC38A2 for western blotting was purchased from MBL (Cat#BMP081), and an antibody against SLC38A2 for immunohistochemical and immunofluorescence staining was purchased from NOVUS (Cat#NBP1-88872).</p></sec><sec id="s4-3"><title>Culture of mIMCD3 cell line</title><p>The established mIMCD3 murine IMCD cell line was originally developed by Rauchman and provided by the American Type Culture Collection. mIMCD3 cells were cultured in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 ( DMEM/F12 ) medium containing 10 mM HEPES, 2 mM L-glutamine, 100 IU/mL penicillin, and 100 IU/mL streptomycin at 37°C in a humidified 5% CO<sub>2</sub> atmosphere. For mIMCD3 cells, short tandem repeats identification was performed, and the results showed that the cells were free of mycoplasma contamination.</p></sec><sec id="s4-4"><title>Primary culture of mouse inner medullary collecting duct cells</title><p>Mouse primary collecting duct cells were cultured as previously described, with minor modifications (<xref ref-type="bibr" rid="bib39">Xu et al., 2018</xref>). In brief, four 8-wk-old male C57BL/6 mice were sacrificed by cervical dislocation, and the kidneys were removed under sterile conditions, placed in sterile PBS buffer, and washed three times. The kidneys were then placed in DMEM/F12 culture solution to separate the renal cortex and the medulla. Renal inner medulla samples were digested in a hyperosmotic enzyme solution containing 12 mL of DMEM/F12 supplemented with 120 mM NaCl, 80 mM urea, 24 mg collagenase (Sigma), and 8.5 mg hyaluronidase (Sigma) at 37°C for 1 h. The digested cell suspension was centrifuged at 1000 rpm for 5 min, and the supernatant was discarded. The IMCD cell pellets were finally resuspended in hyperosmotic DMEM/F12 medium containing 10 mM HEPES, 2 mM L-glutamine, 100 IU/mL penicillin, 100 IU/mL streptomycin, 50 nM hydrocortisone, 5 pM 3,3,5-triiodo-L-thyronine, 1 nM sodium selenate, 5 mg/L transferrin, and 10% foetal bovine serum. To maintain the physiological function of primary IMCD cells, the cells were grown in transwell chambers with 0.4 μm pores (Corning) and routinely maintained in a hyperosmotic (600 mOsm) medium.</p></sec><sec id="s4-5"><title>Cell ultrastructure examination by transmission electron microscopy</title><p>mIMCD3 cells were scraped using a cell scraper and centrifuged at 400 ×<italic>g</italic> for 10 min. After the supernatant was discarded, 3% glutaraldehyde fixative solution was added to the tube to suspend the cells. Next, the cells were fixed with 1% glutaraldehyde in 0.1 M PBS (pH 7.4) at 4°C for 2.5 h, dehydrated through an ethanol gradient, and finally embedded in Spurr’s resin. The fixed cells were photographed using a transmission electron microscope (HT7800; Hitachi, Japan) at different magnifications.</p></sec><sec id="s4-6"><title>RNA-Seq analysis of the IMCD transcriptome</title><p>mIMCD3 cells were cultured in either isosmotic or hyperosmotic medium for 6 h. Total RNA was then isolated, and only samples with an RNA integrity number greater than 8.0 were selected for further analysis. After the samples were subjected to quality control, the mRNA was enriched. Sequencing and analysis were performed by Novogene Corporation (Beijing, China), and the protocol included quality control analysis, read mapping to the reference genome, transcriptome assembly, coding potential analysis, conservative analysis, target gene prediction, gene expression level quantification, and differential expression analysis. To ensure that the gene expression levels estimated from the different genes and experiments were comparable, the expected number of Fragments Per Kilobase of transcript sequence per million base pairs sequenced was used. The URL of the dataset is <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206476">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206476</ext-link>.</p></sec><sec id="s4-7"><title>Real-time PCR</title><p>Real-time PCR was used to measure the mRNA levels of messenger RNA. Briefly, total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA), quantified using NanoDrop 2000 (Thermo Fisher Scientific), and reverse-transcribed to cDNA. Primers were obtained from Thermo Fisher Scientific, according to the manufacturer’s instructions, and are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. β-actin was used as an internal standard. SYBR Green (Invitrogen; Thermo Fisher Scientific) was used as the fluorochrome according to the manufacturer’s instructions. PCR amplification was performed on an ABI 7300 plus (Thermo Fisher Scientific) system at 94°C for 5 min and 35 cycles of 94°C for 30 s, 59°C for 30 s, and 72°C for 30 s, followed by extension at 72°C for 5 min.</p></sec><sec id="s4-8"><title>Western blotting analysis</title><p>Mouse primary IMCD cells, mIMCD3 cells, or mouse renal medulla tissues were lysed in Radio Immunoprecipitation Assay ( RIPA ) buffer containing protease inhibitor cocktail (HY-K0010, MedChemExpress). The lysates were then centrifuged at 12,000 ×<italic>g</italic> at 4°C for 15 min, and the supernatants were collected for immunoblotting analysis. Protein concentrations were determined using the Pierce BCA kit (Thermo Fisher Scientific). Cell lysates were mixed with SDS-PAGE loading buffer, fractionated with 10% SDS-PAGE, and transferred onto polyvinylidene fluoride membranes. The membranes were then incubated with the primary antibodies overnight at 4°C, followed by incubation with the appropriate secondary antibodies for 1 h at 25°C. Finally, the membranes were incubated with SuperLumia ECL Plus HRP Substrate Reagent, and signals from immunoreactive bands were visualised using a Chemiluminescent Imaging System (Tanon 5200; Shanghai, China).</p></sec><sec id="s4-9"><title>Immunohistochemical assay</title><p>For immunohistochemical analysis, tissue sections (4 μm) were dewaxed and rehydrated. The slides were then immersed in 3% H<sub>2</sub>O<sub>2</sub> for 8 min at 25°C to eliminate endogenous peroxidases. The primary antibodies were added at an appropriate dilution, followed by incubation overnight at 4°C in a wet box. The secondary antibodies labelled with the corresponding horseradish peroxidase were then applied and incubated at 25°C or 1 h. Finally, the slides were stained with 3,3’-diaminobenzidine and haematoxylin.</p></sec><sec id="s4-10"><title>Immunofluorescence assay</title><p>Mouse primary IMCD cells or mIMCD3 cells were washed three times with 1× PBS and then embedded in 4% paraffin wax (PFA) for 15 min. After the PFA was removed, the cells were incubated with 0.1% bovine serum albumin (BSA) at 25°C or 30 min. After incubation with a primary antibody against SLC38A2 or NF-κB at an appropriate dilution, the sections were treated with Fluorescein Isothiocyanate (FITC) -labelled Alexa Fluor‐488‐ and/or Alexa Fluor‐594‐conjugated secondary antibody at a 1:1000 dilution for 1 h. The sections were then covered with 4',6-diamidino-2-phenylindole (DAPI), Fluoromount‐G (Southern Biotech). The stained cells were visualised and photographed using a confocal microscope (Leica, Germany). DAPI and DID (C1995S; Beyotime, China) were used to visualise nuclei and cell membranes, respectively.</p></sec><sec id="s4-11"><title>TUNEL assay</title><p>The TUNEL assay was performed using the in situ cell death detection kit (KGA7073, KeyGEN BioTECH, China) following the protocol described. Briefly, the paraffin slides of the kidney were deparaffinised and rehydrated using xylene and a graded series of ethanol. Proteinase K was added and incubated for 30 min at 37°C. Drop 50 µl TdT enzyme reaction solution on slides and put them into a warm box for 60 min at 37℃, away from light. Then add 50 µL streptavidin fluorescein labelling solution to each sample, put them into a wet box, and react in a dark place at 37℃ for 30 min. The nucleus was stained with DAPI staining solution, and the reaction was kept away from light at 25℃ for 10 min.</p></sec><sec id="s4-12"><title>Luciferase reporter assay</title><p>A mouse <italic>Slc38a2</italic> promoter-driven luciferase reporter was constructed. Briefly, the mouse Slc38a2 promoter region was amplified from the tail-derived genomic DNA of a C57BL/6 mouse. The mouse <italic>Slc38a2</italic> promoter region containing the fragment −1799 to + 124 bp was amplified by PCR with the primers 5′-<named-content content-type="sequence">TCC TGC AGT ATG AAC CAT GGA A</named-content>-3′ (forward primer) and 5′- A<named-content content-type="sequence">CA GGC AGA AGA GGT GGA</named-content>-3′ (reverse primer). The amplified fragment was cloned into the luciferase reporter gene vector PGL3-basic (Promega, Madison, WI, USA), and the resultant construct, designated as m<italic>Slc38a2</italic>-luci, was sequenced to validate its orientation and sequence. Next, m<italic>Slc38a2</italic>-luci was truncated into three different lengths (AuGCT Biotechnology, Beijing, China), including −1435 bp to + 124 bp, −961 bp to +124 bp, and −473 bp to + 124 bp (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). All constructs were confirmed by DNA sequencing. The binding sites of the transcription factors in the mouse <italic>Slc38a2</italic> promoter region were predicted using PROMO (<ext-link ext-link-type="uri" xlink:href="http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF">http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF</ext-link>_8.3/). To determine luciferase activity, HEK293T cells were seeded in 24-well plates at a density of 2.0 × 10<sup>5</sup> cells/well. After grown to 50–60% confluence, the cells were transfected with the plasmids using the Lipofectamine 3000 Transfection Reagent. Mouse NF-κB expression plasmid (250 ng; OriGene Technologies, Beijing, China), <italic>Slc38a2</italic> gene promoter-driven luciferase reporter construct (250 ng), and an internal reference PRL-CMV plasmid (25 ng; Promega) were transfected into HEK293T cells. After incubation for 24 h, the cells were harvested in luciferase lysis buffer for the detection of luciferase activity, which was normalised to <italic>Renilla</italic> luciferase activity.</p></sec><sec id="s4-13"><title>Chromatin immunoprecipitation assay</title><p>The ChIP assay was performed using a ChIP-IT Express Chromatin Immunoprecipitation Kit (Active Motif, Carlsbad, CA, USA) according to the manufacturer’s protocol. Upon reaching 90% confluence, mIMCD3 cells were incubated with an isosmotic (300 mOsm) or hyperosmotic solution (600 mOsm) for 12 h, followed by immunoprecipitation at 4°C overnight with anti-NF-κB antibody (R&amp;D Systems) or normal rabbit IgG as a control. The precipitated DNA was analysed by RT-PCR using the following primers: 5′-<named-content content-type="sequence">GCA CCA GGT CAA ACT CGT T</named-content>-3′ (forward primer) and 5′-<named-content content-type="sequence">CCT GGA GCT TTC TCT ACA G</named-content>-3′ (reverse primer). The amplified product (201 bp) was examined by electrophoresis and then sequenced. Quantitative statistics of the purified DNA precipitated by NF-κB were used for enrichment fold statistics using real-time PCR.</p></sec><sec id="s4-14"><title>Transfection and adenovirus infection</title><p>mIMCD3 cells were transfected with <italic>Slc38a2</italic> siRNA or mouse <italic>Slc38a2</italic>-C-EGFP plasmid using Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer’s instructions. <italic>Slc38a2</italic> siRNA was purchased from GenePharma (Shanghai, China). Specific siRNA sequences are listed below. The primers used for <italic>Slc38a2</italic>-mus-1704 were 5′-CUG CCA UGC UGA UCU UUA UTT-3′ (sense) and 5′-AUA AAG AUC AGC AUG GCA GTT-3′ (antisense). A full-length cDNA sequence (NM_175121) of mouse <italic>Slc38a2</italic> was cloned into the vector pex1‐C‐EGFP to express an EGFP-SLC38A2 fusion protein, hereafter referred to as the <italic>Slc38a2</italic>‐C-EGFP plasmid. To overexpress SLC38A2, the cells were infected with an adenovirus carrying a cDNA encoding mouse full-length <italic>Slc38a2</italic> (Ad-SLC38A2) or an adenovirus carrying a cDNA encoding <italic>Gfp</italic> (Ad-GFP) for 24–36 h at a multiplicity of infection sufficient to infect &gt;95% of the cells.</p></sec><sec id="s4-15"><title>Cell viability assay</title><p>Cell viability was determined using the MTT assay as previously described (<xref ref-type="bibr" rid="bib46">Zheng et al., 2014</xref>). mIMCD3 cells were grown to 70–80% confluence in 24-well plates and subjected to hyperosmotic stress for an indicated period of time in the presence or absence of Ad-SLC38A2 ferroptosis agonists and inhibitors. MTT solution (5 mg/mL) was then added to the medium to a final concentration of 0.5 mg/mL. The cells were then cultured for another 2–4 h. At the end of the incubation period, the medium was carefully removed, and the formed MTT formazan crystals were dissolved by incubation in 500 μL of DMSO at 25°C in the dark for 15 min. Finally, the absorbance was measured at 490 nm using a microplate reader (TECAN, Mannedorf, Switzerland).</p></sec><sec id="s4-16"><title>Flow cytometry analysis of lipid ROS production</title><p>mIMCD3 cells were seeded in six-well plates, treated with the indicated compounds, and then subjected to hyperosmotic treatment. The cells were harvested after trypsinisation, resuspended in 500  μL of PBS containing 10  μM C11-BODIPY (581/591) (Cat #D3861; Invitrogen), and incubated for 30  min at 37°C in a tissue culture incubator. The cells were then resuspended in 500  μL of fresh PBS containing 2.5% BSA, strained through a 40 μm cell strainer, and analysed using a flow cytometer (FACSuite; BD Biosciences) equipped with a 488  nm laser for excitation.</p></sec><sec id="s4-17"><title>Total glutathione peroxidase detection</title><p>The cells were lysed on ice and then centrifuged at 12,000 ×<italic>g</italic> for 10 min at 4°C to collect the supernatant, which was then used to determine the enzymatic activity. The GPx activity of the cells was determined using a Total Glutathione Peroxidase Assay Kit (S0059S; Beyotime), according to the manufacturer’s protocol. The protein concentration of the cells was determined using a Bradford dye-binding assay kit (P0006; Beyotime) (<xref ref-type="bibr" rid="bib4">Bradford, 1976</xref>).</p></sec><sec id="s4-18"><title>Glutathione measurement in tissues</title><p>Renal medullary tissue was frozen in liquid nitrogen and ground into a powder. For each 10 mg of ground tissue powder, 30 μL of the protein removal reagent M solution was added, and the mixture was vortexed. Next, an additional 70 μL of protein removal reagent M solution was added, and the mixture was fully homogenised using a glass homogeniser. The samples were then placed at 4°C for 10 min, followed by centrifugation at 10,000 ×<italic>g</italic> at 4°C for 10 min. The supernatant was collected, and the levels of glutathione reductive (GSH) and oxidised (GSSG) were determined using a commercial assay kit (S0053; Beyotime) according to the manufacturer’s protocol.</p></sec><sec id="s4-19"><title>Iron assay</title><p>Tissue samples were obtained after the animals were perfused with normal saline (0.9% NaCl, containing 0.16 mg/mL heparin sodium) to clear the blood. The renal medulla was dissected, frozen in liquid nitrogen, and ground into powder. For each 100 mg of ground tissue powder, 900 μL of iron assay buffer was added for homogenisation, and then the mixture was centrifuged at 10,000 ×<italic>g</italic> for 10 min to remove insoluble cellular debris. Protein concentration in the tissue was determined using a Pierce BCA kit (Thermo Fisher Scientific). The supernatant was used to measure Fe<sup>2+</sup> levels using an assay kit (K773; Elabscience) according to the manufacturer’s protocol.</p></sec><sec id="s4-20"><title>Measurement of lipid peroxidation</title><p>Renal medullary tissues were lysed in PBS, and the lysates were centrifuged at 12,000 ×<italic>g</italic> for 10 min at 4°C to collect the supernatant. The protein concentration of the supernatant was determined using a Pierce BCA kit (Thermo Fisher Scientific). MDA levels in the supernatant were measured using a kit (S0131S; Beyotime) according to the manufacturer’s protocol.</p></sec><sec id="s4-21"><title>Measurement of total SOD activity</title><p>Renal medullary tissue samples were homogenised at 4°C in an SOD sample preparation solution and then centrifuged at 12,000 ×<italic>g</italic> at 4°C for 3–5 min. The supernatant was collected and used to measure the SOD activity with a kit (S0101S; Beyotime) according to the manufacturer’s instructions.</p></sec><sec id="s4-22"><title>Measurement of caspase-3 activity</title><p>The activity of caspase-3 in renal medulla tissues was determined using the Caspase-3 Activity Assay Kit (C1116; Beyotime) according to the manufacturer’s instructions. Briefly, after homogenisation of renal medulla tissue in cell lysis buffer, homogenates were centrifuged for 10 min at 16,000 ×<italic>g</italic>, and the supernatant was incubated with Ac-DEVD-<italic>p</italic>NA and reaction buffer for 90 min at 37°C. Caspase-3 activity was quantified in the samples at an absorbance of 405 nm according to the manufacturer’s protocol. Protein concentrations in the tissue samples were determined using the Bradford method (P0006; Beyotime).</p></sec><sec id="s4-23"><title>Statistical analysis</title><p>Data are presented as the mean ± SEM. Statistical analyses were performed using the GraphPad Prism 8.0 software. All experiments were performed with a minimum of three biological replicates; the number of replicates is indicated in the figure legends. The details of the statistical tests are indicated in the figure legends. p&lt;0.05 was regarded as the standard of significant difference.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Validation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Supervision, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Software</p></fn><fn fn-type="con" id="con11"><p>Data curation</p></fn><fn fn-type="con" id="con12"><p>Formal analysis</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The use of animals and the study protocols were reviewed and approved by the Animal Care and Use Review Committee of Dalian Medical University and the study conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (in Guide for the Care and Use of Laboratory Animals, th, Editor. 2011: Washington).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-80647-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primer pairs used for real-time PCR to determine the mRNA levels of <italic>Slc38a2</italic>.</title></caption><media xlink:href="elife-80647-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE206476. All data analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures and Figure supplements.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Neutral amino acid transporter SNAT2 protects renal medulla from hypertonicity-induced ferroptosis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206476">GSE206476</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Ransick</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Single-Cell Profiling Reveals Sex, Lineage, and Regional Diversity in the Mouse Kidney</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://cello.shinyapps.io/kidneycellexplorer/">GSE129798</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the National Natural Science Foundation of China Grants 82270703 (to XY), 81970606 (to XY), and 81970595 (to YF); the National Key R&amp;D Program of China (2020YFC2005000); and the East China Normal University Medicine and Health Joint Fund (2022JKXYD03001).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfieri</surname><given-names>RR</given-names></name><name><surname>Cavazzoni</surname><given-names>A</given-names></name><name><surname>Petronini</surname><given-names>PG</given-names></name><name><surname>Bonelli</surname><given-names>MA</given-names></name><name><surname>Caccamo</surname><given-names>AE</given-names></name><name><surname>Borghetti</surname><given-names>AF</given-names></name><name><surname>Wheeler</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis</article-title><source>The Journal of Physiology</source><volume>540</volume><fpage>499</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2001.013395</pub-id><pub-id pub-id-type="pmid">11956339</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevilacqua</surname><given-names>E</given-names></name><name><surname>Bussolati</surname><given-names>O</given-names></name><name><surname>Dall’Asta</surname><given-names>V</given-names></name><name><surname>Gaccioli</surname><given-names>F</given-names></name><name><surname>Sala</surname><given-names>R</given-names></name><name><surname>Gazzola</surname><given-names>GC</given-names></name><name><surname>Franchi-Gazzola</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Snat2 silencing prevents the osmotic induction of transport system A and hinders cell recovery from hypertonic stress</article-title><source>FEBS Letters</source><volume>579</volume><fpage>3376</fpage><lpage>3380</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2005.05.002</pub-id><pub-id pub-id-type="pmid">15922329</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittner</surname><given-names>S</given-names></name><name><surname>Knoll</surname><given-names>G</given-names></name><name><surname>Ehrenschwender</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hyperosmotic stress enhances cytotoxicity of smac mimetics</article-title><source>Cell Death &amp; Disease</source><volume>8</volume><elocation-id>e2967</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2017.355</pub-id><pub-id pub-id-type="pmid">28771230</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source>Analytical Biochemistry</source><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1006/abio.1976.9999</pub-id><pub-id pub-id-type="pmid">942051</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JG</given-names></name><name><surname>Kempson</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Osmoregulation of neutral amino acid transport</article-title><source>Experimental Biology and Medicine</source><volume>210</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3181/00379727-210-43917A</pub-id><pub-id pub-id-type="pmid">7675792</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ferroptosis: machinery and regulation</article-title><source>Autophagy</source><volume>17</volume><fpage>2054</fpage><lpage>2081</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1810918</pub-id><pub-id pub-id-type="pmid">32804006</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>An amino acid shuffle activates mtorc1</article-title><source>Cell</source><volume>136</volume><fpage>399</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.01.021</pub-id><pub-id pub-id-type="pmid">19203575</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cormerais</surname><given-names>Y</given-names></name><name><surname>Vučetić</surname><given-names>M</given-names></name><name><surname>Parks</surname><given-names>SK</given-names></name><name><surname>Pouyssegur</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Amino acid transporters are a vital focal point in the control of mTORC1 signaling and cancer</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22010023</pub-id><pub-id pub-id-type="pmid">33375025</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dall’Asta</surname><given-names>V</given-names></name><name><surname>Bussolati</surname><given-names>O</given-names></name><name><surname>Sala</surname><given-names>R</given-names></name><name><surname>Parolari</surname><given-names>A</given-names></name><name><surname>Alamanni</surname><given-names>F</given-names></name><name><surname>Biglioli</surname><given-names>P</given-names></name><name><surname>Gazzola</surname><given-names>GC</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Amino acids are compatible osmolytes for volume recovery after hypertonic shrinkage in vascular endothelial cells</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>276</volume><fpage>C865</fpage><lpage>C872</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1999.276.4.C865</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dmitrieva</surname><given-names>N</given-names></name><name><surname>Kultz</surname><given-names>D</given-names></name><name><surname>Michea</surname><given-names>L</given-names></name><name><surname>Ferraris</surname><given-names>J</given-names></name><name><surname>Burg</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Protection of renal inner medullary epithelial cells from apoptosis by hypertonic stress-induced p53 activation</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>18243</fpage><lpage>18247</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000522200</pub-id><pub-id pub-id-type="pmid">10747924</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dmitrieva</surname><given-names>NI</given-names></name><name><surname>Michea</surname><given-names>LF</given-names></name><name><surname>Rocha</surname><given-names>GM</given-names></name><name><surname>Burg</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cell cycle delay and apoptosis in response to osmotic stress</article-title><source>Comparative Biochemistry and Physiology. Part A, Molecular &amp; Integrative Physiology</source><volume>130</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/s1095-6433(01)00439-1</pub-id><pub-id pub-id-type="pmid">11913454</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dmitrieva</surname><given-names>NI</given-names></name><name><surname>Burg</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hypertonic stress response</article-title><source>Mutation Research</source><volume>569</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2004.06.053</pub-id><pub-id pub-id-type="pmid">15603752</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franchi-Gazzola</surname><given-names>R</given-names></name><name><surname>Dall’Asta</surname><given-names>V</given-names></name><name><surname>Sala</surname><given-names>R</given-names></name><name><surname>Visigalli</surname><given-names>R</given-names></name><name><surname>Bevilacqua</surname><given-names>E</given-names></name><name><surname>Gaccioli</surname><given-names>F</given-names></name><name><surname>Gazzola</surname><given-names>GC</given-names></name><name><surname>Bussolati</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The role of the neutral amino acid transporter SNAT2 in cell volume regulation</article-title><source>Acta Physiologica</source><volume>187</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2006.01552.x</pub-id><pub-id pub-id-type="pmid">16734764</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome</article-title><source>Journal of the American Society of Nephrology</source><volume>15</volume><fpage>2801</fpage><lpage>2815</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000139067.83419.46</pub-id><pub-id pub-id-type="pmid">15504933</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ampk potentiates hypertonicity-induced apoptosis by suppressing nfκb/COX-2 in medullary interstitial cells</article-title><source>Journal of the American Society of Nephrology</source><volume>22</volume><fpage>1897</fpage><lpage>1911</lpage><pub-id pub-id-type="doi">10.1681/ASN.2010080822</pub-id><pub-id pub-id-type="pmid">21903993</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasler</surname><given-names>U</given-names></name><name><surname>Leroy</surname><given-names>V</given-names></name><name><surname>Jeon</surname><given-names>US</given-names></name><name><surname>Bouley</surname><given-names>R</given-names></name><name><surname>Dimitrov</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name><name><surname>Martin</surname><given-names>PY</given-names></name><name><surname>Féraille</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nf-kappab modulates aquaporin-2 transcription in renal collecting duct principal cells</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>28095</fpage><lpage>28105</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708350200</pub-id><pub-id pub-id-type="pmid">18703515</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensley</surname><given-names>CT</given-names></name><name><surname>Wasti</surname><given-names>AT</given-names></name><name><surname>DeBerardinis</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glutamine and cancer: cell biology, physiology, and clinical opportunities</article-title><source>The Journal of Clinical Investigation</source><volume>123</volume><fpage>3678</fpage><lpage>3684</lpage><pub-id pub-id-type="doi">10.1172/JCI69600</pub-id><pub-id pub-id-type="pmid">23999442</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horio</surname><given-names>M</given-names></name><name><surname>Yamauchi</surname><given-names>A</given-names></name><name><surname>Moriyama</surname><given-names>T</given-names></name><name><surname>Imai</surname><given-names>E</given-names></name><name><surname>Orita</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Osmotic regulation of amino acids and system A transport in madin-darby canine kidney cells</article-title><source>The American Journal of Physiology</source><volume>272</volume><fpage>C804</fpage><lpage>C809</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1997.272.3.C804</pub-id><pub-id pub-id-type="pmid">9124514</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikari</surname><given-names>A</given-names></name><name><surname>Atomi</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Sugatani</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hyperosmolarity-induced up-regulation of claudin-4 mediated by NADPH oxidase-dependent H2O2 production and sp1/c-jun cooperation</article-title><source>Biochimica et Biophysica Acta</source><volume>1833</volume><fpage>2617</fpage><lpage>2627</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.06.016</pub-id><pub-id pub-id-type="pmid">23816505</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Stockwell</surname><given-names>BR</given-names></name><name><surname>Conrad</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ferroptosis: mechanisms, biology and role in disease</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>22</volume><fpage>266</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-00324-8</pub-id><pub-id pub-id-type="pmid">33495651</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Küper</surname><given-names>C</given-names></name><name><surname>Bartels</surname><given-names>H</given-names></name><name><surname>Beck</surname><given-names>FX</given-names></name><name><surname>Neuhofer</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein bad inhibits tonicity-induced apoptosis in renal medullary cells</article-title><source>Kidney International</source><volume>80</volume><fpage>938</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1038/ki.2011.199</pub-id><pub-id pub-id-type="pmid">21716255</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Lim</surname><given-names>SW</given-names></name><name><surname>Lamitina</surname><given-names>ST</given-names></name><name><surname>Ho</surname><given-names>SN</given-names></name><name><surname>Go</surname><given-names>WY</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tonebp stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and -independent pathways</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>300</volume><fpage>F707</fpage><lpage>F715</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00227.2010</pub-id><pub-id pub-id-type="pmid">21209002</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>F</given-names></name><name><surname>Yin</surname><given-names>HL</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Lin</surname><given-names>ZT</given-names></name><name><surname>Mao</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ferroptosis: past, present and future</article-title><source>Cell Death &amp; Disease</source><volume>11</volume><elocation-id>88</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-020-2298-2</pub-id><pub-id pub-id-type="pmid">32015325</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>P</given-names></name><name><surname>Zha</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nfat5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium</article-title><source>Cell Communication and Signaling</source><volume>17</volume><elocation-id>102</elocation-id><pub-id pub-id-type="doi">10.1186/s12964-019-0406-7</pub-id><pub-id pub-id-type="pmid">31429763</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>B</given-names></name><name><surname>Erickson</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sodium-coupled neutral amino acid (system N/A) transporters of the SLC38 gene family</article-title><source>Pflugers Archiv</source><volume>447</volume><fpage>784</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1007/s00424-003-1117-9</pub-id><pub-id pub-id-type="pmid">12845534</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeckel</surname><given-names>GW</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Fogo</surname><given-names>AB</given-names></name><name><surname>Hao</surname><given-names>CM</given-names></name><name><surname>Pozzi</surname><given-names>A</given-names></name><name><surname>Breyer</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cox2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>19352</fpage><lpage>19357</lpage><pub-id pub-id-type="doi">10.1074/jbc.M302209200</pub-id><pub-id pub-id-type="pmid">12637551</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahm</surname><given-names>O</given-names></name><name><surname>Woo</surname><given-names>SK</given-names></name><name><surname>Handler</surname><given-names>JS</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>282</volume><fpage>C49</fpage><lpage>C58</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00267.2001</pub-id><pub-id pub-id-type="pmid">11742797</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhofer</surname><given-names>W</given-names></name><name><surname>Holzapfel</surname><given-names>K</given-names></name><name><surname>Fraek</surname><given-names>ML</given-names></name><name><surname>Ouyang</surname><given-names>N</given-names></name><name><surname>Lutz</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>FX</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Chronic COX-2 inhibition reduces medullary hsp70 expression and induces papillary apoptosis in dehydrated rats</article-title><source>Kidney International</source><volume>65</volume><fpage>431</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00387.x</pub-id><pub-id pub-id-type="pmid">14717913</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicklin</surname><given-names>P</given-names></name><name><surname>Bergman</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Triantafellow</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Nyfeler</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Hild</surname><given-names>M</given-names></name><name><surname>Kung</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Myer</surname><given-names>VE</given-names></name><name><surname>MacKeigan</surname><given-names>JP</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>YK</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Murphy</surname><given-names>LO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bidirectional transport of amino acids regulates mtor and autophagy</article-title><source>Cell</source><volume>136</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.11.044</pub-id><pub-id pub-id-type="pmid">19203585</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>R</given-names></name><name><surname>Usuda</surname><given-names>M</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name><name><surname>Suda</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Okazaki</surname><given-names>F</given-names></name><name><surname>Sai</surname><given-names>Y</given-names></name><name><surname>Higuchi</surname><given-names>K</given-names></name><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Tomi</surname><given-names>M</given-names></name><name><surname>Nakashima</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>System A amino acid transporter SNAT2 shows subtype-specific affinity for betaine and hyperosmotic inducibility in placental trophoblasts</article-title><source>Biochimica et Biophysica Acta-Biomembranes</source><volume>1838</volume><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2014.01.004</pub-id><pub-id pub-id-type="pmid">24434061</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>P</given-names></name><name><surname>Ernandez</surname><given-names>T</given-names></name><name><surname>Roth</surname><given-names>I</given-names></name><name><surname>Qiao</surname><given-names>X</given-names></name><name><surname>Strebel</surname><given-names>D</given-names></name><name><surname>Bouley</surname><given-names>R</given-names></name><name><surname>Charollais</surname><given-names>A</given-names></name><name><surname>Ramadori</surname><given-names>P</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name><name><surname>Meda</surname><given-names>P</given-names></name><name><surname>Féraille</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Hasler</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clusters</article-title><source>Autophagy</source><volume>9</volume><fpage>550</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.4161/auto.23662</pub-id><pub-id pub-id-type="pmid">23380587</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petronini</surname><given-names>PG</given-names></name><name><surname>Alfieri</surname><given-names>RR</given-names></name><name><surname>Losio</surname><given-names>MN</given-names></name><name><surname>Caccamo</surname><given-names>AE</given-names></name><name><surname>Cavazzoni</surname><given-names>A</given-names></name><name><surname>Bonelli</surname><given-names>MA</given-names></name><name><surname>Borghetti</surname><given-names>AF</given-names></name><name><surname>Wheeler</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Induction of BGT-1 and amino acid system A transport activities in endothelial cells exposed to hyperosmolarity</article-title><source>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</source><volume>279</volume><fpage>R1580</fpage><lpage>R1589</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.2000.279.5.R1580</pub-id><pub-id pub-id-type="pmid">11049839</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santagostino</surname><given-names>SF</given-names></name><name><surname>Assenmacher</surname><given-names>CA</given-names></name><name><surname>Tarrant</surname><given-names>JC</given-names></name><name><surname>Adedeji</surname><given-names>AO</given-names></name><name><surname>Radaelli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanisms of regulated cell death: current perspectives</article-title><source>Veterinary Pathology</source><volume>58</volume><fpage>596</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1177/03009858211005537</pub-id><pub-id pub-id-type="pmid">34039100</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Pruett-Miller</surname><given-names>SM</given-names></name><name><surname>Zhang</surname><given-names>GF</given-names></name><name><surname>Karner</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Slc38A2 provides proline to fulfill unique synthetic demands arising during osteoblast differentiation and bone formation</article-title><source>eLife</source><volume>11</volume><elocation-id>e76963</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.76963</pub-id><pub-id pub-id-type="pmid">35261338</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trama</surname><given-names>J</given-names></name><name><surname>Go</surname><given-names>WY</given-names></name><name><surname>Ho</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The osmoprotective function of the NFAT5 transcription factor in T cell development and activation</article-title><source>The Journal of Immunology</source><volume>169</volume><fpage>5477</fpage><lpage>5488</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.10.5477</pub-id><pub-id pub-id-type="pmid">12421923</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidenfeld</surname><given-names>S</given-names></name><name><surname>Chupin</surname><given-names>C</given-names></name><name><surname>Langner</surname><given-names>DI</given-names></name><name><surname>Zetoun</surname><given-names>T</given-names></name><name><surname>Rozowsky</surname><given-names>S</given-names></name><name><surname>Kuebler</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sodium-coupled neutral amino acid transporter SNAT2 counteracts cardiogenic pulmonary edema by driving alveolar fluid clearance</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>320</volume><fpage>L486</fpage><lpage>L497</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00461.2020</pub-id><pub-id pub-id-type="pmid">33439101</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>SK</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Adaptation of kidney medulla to hypertonicity: role of the transcription factor tonebp</article-title><source>International Review of Cytology</source><volume>215</volume><fpage>189</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/s0074-7696(02)15009-1</pub-id><pub-id pub-id-type="pmid">11952228</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Na</surname><given-names>KY</given-names></name><name><surname>Park</surname><given-names>WK</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Tonebp/nfat5 stimulates transcription of hsp70 in response to hypertonicity</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>5753</fpage><lpage>5760</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.16.5753-5760.2002</pub-id><pub-id pub-id-type="pmid">12138186</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Luan</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Gustafsson</surname><given-names>JÅ</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress</article-title><source>PNAS</source><volume>115</volume><fpage>5600</fpage><lpage>5605</lpage><pub-id pub-id-type="doi">10.1073/pnas.1803945115</pub-id><pub-id pub-id-type="pmid">29739889</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>A</given-names></name><name><surname>Miyai</surname><given-names>A</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Kamada</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>N</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Response to osmotic stimuli in mesangial cells: role of system A transporter</article-title><source>The American Journal of Physiology</source><volume>267</volume><fpage>C1493</fpage><lpage>C1500</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1994.267.5.C1493</pub-id><pub-id pub-id-type="pmid">7977710</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Ai</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1</article-title><source>Molecular Cell</source><volume>81</volume><fpage>355</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.024</pub-id><pub-id pub-id-type="pmid">33321093</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Honeggar</surname><given-names>M</given-names></name><name><surname>Kohan</surname><given-names>DE</given-names></name><name><surname>Mizel</surname><given-names>D</given-names></name><name><surname>Sanders</surname><given-names>K</given-names></name><name><surname>Hoidal</surname><given-names>JR</given-names></name><name><surname>Briggs</surname><given-names>JP</given-names></name><name><surname>Schnermann</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>34966</fpage><lpage>34973</lpage><pub-id pub-id-type="doi">10.1074/jbc.M502430200</pub-id><pub-id pub-id-type="pmid">16024921</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Bi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Regulation of ferroptosis by amino acid metabolism in cancer</article-title><source>International Journal of Biological Sciences</source><volume>18</volume><fpage>1695</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.7150/ijbs.64982</pub-id><pub-id pub-id-type="pmid">35280684</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Gustafsson</surname><given-names>JÅ</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice</article-title><source>PNAS</source><volume>111</volume><fpage>2277</fpage><lpage>2282</lpage><pub-id pub-id-type="doi">10.1073/pnas.1323977111</pub-id><pub-id pub-id-type="pmid">24464484</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Regulation of mtorc1 by amino acids in mammalian cells: a general picture of recent advances</article-title><source>Animal Nutrition</source><volume>7</volume><fpage>1009</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1016/j.aninu.2021.05.003</pub-id><pub-id pub-id-type="pmid">34738031</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice</article-title><source>Journal of Diabetes</source><volume>6</volume><fpage>132</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12105</pub-id><pub-id pub-id-type="pmid">24405721</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80647.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zeidel</surname><given-names>Mark L</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04drvxt59</institution-id><institution>Beth Israel Deaconess Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>These are nicely done and very complete studies which provide strong evidence that medullary collecting duct cells survive periodic medullary toxicity through upregulation of SLC38A2 , an amino acid transporter which provides substrate for glutathione production in the cells, which is in turn, protective. Cell lines, primary cultures and whole animals are used effectively to strengthen the mechanistic narrative.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80647.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zeidel</surname><given-names>Mark L</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04drvxt59</institution-id><institution>Beth Israel Deaconess Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Schmidt-Ott</surname><given-names>Kai M</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Hannover Medical School</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Neutral amino acid transporter SLC38A2 protects renal medulla from hypertonicity-induced ferroptosis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Martin Pollak as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Reviewer #1. These are very well done studies which make the point convincingly that SLC38A2 plays an important role in protecting IMCD cells from hypertonic stress. The studies are complete and include cultured cell lines, primary cultures and intact mice. I have made a few suggestions about presentation in the public comments. The only consequential question is whether, in the intact mouse, water deprivation alters the upstream regulator (nF-kappaB) and the downstream TORC1 pathway as would be suggested by the studies in the cultured cells.</p><p>(1) For clarity, please consider moving the in vivo studies up in the results. This will motivate the detailed mechanistic studies in the cultured cells. The way the text is now, the reader wonders whether all of the work in cultured cells relates at all to the intact animal. You have such strong data in the intact mouse, that it likely should be moved up earlier in the narrative.</p><p>(2) Since the in vivo results correlate so well with the studies in culture, does water deprivation increase nF-kappaB or TORC1 expression in the intact mouse kidney?</p><p>Reviewer #2. I recommend another thorough proof-read by a native English speaker.</p><p>The terms hyperosmolarity and hypertonicity are used to describe the same experimental condition (hyperosmolarity). I suggest to consistently stick with the term &quot;hyperosmolarity&quot; to avoid confusion.</p><p>Slc38a2 and SLC38A2 are used to describe the same gene/protein. I recommend to use consistent nomenclature (Slc38a2) to avoid confusion.</p><p>Figure 7I does not contribute to the key message of this figure. It would be better to include these data into Figure 6.</p><p>Figure 8A, B were copied and pasted from https://cello.shinyapps.io/kidneycellexplorer/. Although these data support the expression of Slc38a2 mRNA in medullary cells, I suggest to move them into Supplementary Data.</p><p>Figure 8C. Detection of Slc38a2 protein in proximal tubules is surprising and non-consistent with the single cell sequencing data presented in Figure 8A and B. Is this staining specific or background? Control staining with secondary AB only would address this question.</p><p>Figure 9M: Increased TUNEL staining is suggested to be present in renal medullas of Slc38a2 knockout mice compared to control mice. This is an important finding. However, only two images of fluorescent stainings are presented. TUNEL positive cells should be quantitated and evaluated statistically.</p><p>Figure S9: Knockout mice excrete slightly increased urinary volume, but at the same time they display increased urinary osmolarity. This combination of findings is surprising and unexpected. Does this mean that knockout mice excrete more osmolytes than control mice? I would have expected equal osmolyte excretion rates. The authors should discuss this finding.</p><p>Reviewer #3. Show the functional significance of SLC38A2 in vivo by comparing the long-term effects of water deprivation (with and without mTor inhibitor) of WT and ko-mice.</p><p>Explain Tubular gain of function (i.e. increased urine osmolality) with SLC38A2 ko.</p><p>Electron microscopic evidence for ferroptosis in vivo.</p><p>Explain: mOsmo -SLC38A2/NFkB dose response in IMCD3 cells in vivo.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>These studies address the mechanisms by which medullary collecting duct cells survive the rigors of periodic medullary hypertonicity which is needed for urinary concentration. The authors make a convincing case that hypertonicity leads to upregulation of the nF-kappaB pathway, which drives synthesis of the amino acid transporter, SLC38A2, which in turn provides critical amino acid substrates for the synthesis of the oxygen scavenger, glutathione. The studies combine work in cell lines, primary cultures and in the intact mouse. The work starts with an unbiased RNASeq approach which identified the upregulation of the SLC38A2 gene, and the authors then examine, systematically the role of upregulation of SLC38A2 in cell survival, and the pathways involved in SLC38A2 regulation. The studies are convincing and well performed.</p><p>I have only a few comments, which might improve the presentation.</p><p>1. Towards the end of the Results the authors turn to the whole animal, showing that water deprivation upregulates SLC38A2 expression, and showing the localization of SLC38A2 on cell membranes. I might move from the RNASeq to a description of the in vivo results in mice, including the knockout studies. These establish the importance of SLC38A2 in the intact mouse. I would then go on to use the cell culture studies to define the mechanisms involved.</p><p>2. In the intact mouse, does hypertonicity activate nF-KappaB (upstream stimulator of SLC38A2 synthesis) or TORC1 (downstream pathway putatively upregulated by SLC38A2)?</p><p>3. The SLC38A2 -/- mouse has (p 22) polyuria and &quot;increased urine osmotic pressure.&quot; This term is unclear. Do the authors mean, hypotonic urine?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors use a mouse inner medullary collecting duct cell line (mIMCD-3), primary mouse medullary collecting duct (MCD) cells and a genetic mouse model to provide evidence that</p><p>(1) Hyperosmolarity induces cell death in mIMCD-3 cells that displays features of ferroptosis (lipid peroxidation, inhibition by ferroptosis inhibitors, potentiation by ferroptosis inducers)</p><p>(2) Slc38a2 (=SLC38A2), a previously identified neutral amino acid transporter providing substrates for intracellular glutathion (GSH) production, is strongly induced by high osmolarity in mIMCD-3 and primary MCD cells.</p><p>(3) Activation of nuclear factor kappa B (NF-kappaB) in response to hyperosmolarity is an important upstream regulator of Slc38a2 in mIMCD-3 cells.</p><p>(4) Overexpression of Slc38a2 by adenovirus inhibits ferroptosis and that inhibition or downregulation of Slc38a2 aggravates hypertonicity-induced ferroptosis in mIMCD3 and primary IMCD cells.</p><p>(5) Slc38a2 inhibits ferroptosis under hypertonic stress in mIMCD-3 cells by activating mTOR signaling.</p><p>(6) Slc38a2 is expressed in medullary epithelial cells of the mouse nephron and its mRNA and protein is induced in response to water deprivation.</p><p>(7) Water deprived Slc38a2 knockout mice display evidence of ferroptotic cell death in the renal medulla.</p><p>Strengths:</p><p>The study is thoroughly conducted and presented well.</p><p>Extensive in vitro studies are provided using a mouse inner medullary collecting duct cell line and primary mouse medullary collecting duct cells.</p><p>Novel molecular insights into hyperosmolarity-induced regulation of Slc38a2 in collecting duct cells are provided.</p><p>Novel molecular insights into the relationship of Slc38a2 and the prevention of ferroptosis in collecting duct cells are provided.</p><p>in vivo evidence from Slc38a2 knockout mice largely supports the in vitro findings.</p><p>Weaknesses:</p><p>No major weaknesses are identified.</p><p>Conclusion:</p><p>The authors provide important and novel information on the molecular basis of osmotic resistance in the renal medulla. The results are carefully presented and interpreted. The data will be important to the field of renal physiology and might be of relevance to the molecular basis of human disease.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>In their Du et al. describe that hypertonicity induces regulated cell death of IMCD3 and primary renal medullary collecting cells via ferroptosis. They show that hypertonicity induces the neutral amino acid transporter SLC38A2 in these cells and conversely that SLC38A2 depletion or inhibition further increase ferroptosis. These findings are paralleled by in vivo studies showing induction of SLC38A2 in medullary collecting cells and other tubule segments and increased TUNEL signal following water dehydration.</p><p>Strengths:</p><p>The authors put up a model explaining the role of SLC38A2 in the protection of IMCD3 and primary renal medullary collecting cells against hypertonicity, which is supported by the effects of SLC38A2 induction by hypertonicity (mRNA and protein level) in the above cells in vitro. It is further supported by the use of various inhibitors and enhancers of ferroptosis. The authors also show induction of SLC38A2 by NFkB. in vivo, tubular (including IMC ducts) SLC38A2 expression is induced by water deprivation, which is in line with their model. Increased numbers of TUNEL positive cells are observed in SLC38A2 ko mice, consistent with their in vitro data and their model.</p><p>Weakness:</p><p>The authors demonstrate maximal induction of SLC38A2 mRNA and protein and 600 mOsm. However, they also show declining levels SLC38A2 mRNA and protein at 700 and 800 mOsm (Figure 3). The authors only describe the time course of induction but not describe the dose response curve. As urine osmolality can go much higher the question arises why SLC38A2 should be considered protective when its is not expressed in IMCD3 cells with 700 mOsm and higher. So what is the role of SLC38A2 above 600 mOsm?</p><p>Figure S3: Induction of Slco4a1 and Slc5a3 mRNA was much stronger with hyperosmolality compared to the effect on Slc38a2 mRNA. Can the authors exclude a role of the former in protection against hyperosmolality?</p><p>Figure 4: The authors do not explain why they study NFkB. They show that hypertonicity dose-dependently increased NF-κB activity in mIMCD3 cells from 300-800 mOsm. How do the authors reconcile this notion with repression of SLC38A2 expression with 700 and 800 mOsm (Figure 3.)?</p><p>Figure 9: Can the authors provide independent evidence for ferroptosis by performing electron microscopic studies of renal medullae?</p><p>Figure S9: The authors demonstrate increased urine osmolality in SLC38A2 ko mice (despite higher urine output). How do the authors explain the obviously increased medullary osmotic gradient?</p><p>How do the authors explain the &quot;polyuria&quot; under basal (S9b) and challenged conditions (S9e).</p><p>Significantly increased cell death should rather decrease but not increase the medullary osmotic gradient at least during longer term experiments. Such experiments (maybe combined with Tor-inhibitors) may yield insight into the functional role of SLC38A2 in water deprived animals.</p><p>In the discussion, the authors state: &quot;Finally, by using SLC38A2 gene knockout mice, we confirm the critical role of SLC38A2 in maintaining renal medullary homeostasis and renal urine concentration by attenuating medullary cell ferroptosis.&quot; The increased urine osmolality in SLC38A2 ko mice indicates the opposite.</p><p>The authors use different osmolarities ranging between 300-1200 mOsm without explaining why.</p><p>(i.e. Figure 1a-c with 300 and 600 mOSM vs. With 300 and 500 mOSM in Figure 1d-f).</p><p>Figure 9 M: Can the authors localize TUNEL-positivity to either interstitial and/or tubular cells?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80647.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Reviewer #1. These are very well done studies which make the point convincingly that SLC38A2 plays an important role in protecting IMCD cells from hypertonic stress. The studies are complete and include cultured cell lines, primary cultures and intact mice. I have made a few suggestions about presentation in the public comments. The only consequential question is whether, in the intact mouse, water deprivation alters the upstream regulator (nF-kappaB) and the downstream TORC1 pathway as would be suggested by the studies in the cultured cells.</p></disp-quote><p>We appreciate the reviewer for the positive comments on our present work.</p><disp-quote content-type="editor-comment"><p>(1) For clarity, please consider moving the in vivo studies up in the results. This will motivate the detailed mechanistic studies in the cultured cells. The way the text is now, the reader wonders whether all of the work in cultured cells relates at all to the intact animal. You have such strong data in the intact mouse, that it likely should be moved up earlier in the narrative.</p></disp-quote><p>Thank you for the meaningful comment. According to your suggestion, we have moved the in vivo studies up in the result session in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(2) Since the in vivo results correlate so well with the studies in culture, does water deprivation increase nF-kappaB or TORC1 expression in the intact mouse kidney?</p></disp-quote><p>Thank you for the valuable question. As suggested by the reviewer, we have measured the levels of NF-κB and mTORC1. As shown in Figure 6C in the revised manuscript, water deprivation upregulated the p-NF-κB expression in the renal medullas of wild-type mice, suggesting that the NF-κB pathway is activated in dehydrated mouse kidneys. In addition, water deprivation markedly downregulated the p-S6 and p-4E-BP1 expression in renal medullas, indicating that the mTORC1 pathway is suppressed in the kidneys of dehydrated mice (please see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>).</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Effect of water restriction on renal medullary mTOC1 activity.</title><p>Water deprivation significantly decreased p-S6 and p-4E-BP1 protein levels in renal medullas of wild-type C57BL/6 mice. The mice were subjected to water deprivation (WD) for 24 h or free access to water (Control).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Reviewer #2.</p><p>I recommend another thorough proof-read by a native English speaker.</p></disp-quote><p>Thank you very much for your suggestion. We have invited a professional native English speaker to edit our manuscript.</p><disp-quote content-type="editor-comment"><p>The terms hyperosmolarity and hypertonicity are used to describe the same experimental condition (hyperosmolarity). I suggest to consistently stick with the term &quot;hyperosmolarity&quot; to avoid confusion.</p></disp-quote><p>We sincerely thank the reviewer for your careful reading. As suggested, we have replaced the term “hypertonicity” by “hyperosmolarity” in the revised manuscript to avoid confusion.</p><disp-quote content-type="editor-comment"><p>Slc38a2 and SLC38A2 are used to describe the same gene/protein. I recommend to use consistent nomenclature (Slc38a2) to avoid confusion.</p></disp-quote><p>Thank you very much for your suggestion. As the reviewer suggested, we have changed the word “SLC38A2” to “Slc38a2” in the entire manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 7I does not contribute to the key message of this figure. It would be better to include these data into Figure 6.</p></disp-quote><p>Thank the reviewer for the valuable suggestion. As suggested, we have moved the Figure 7I to Figure 6J in the original paper, which is now shown in new Figure 8J in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 8A, B were copied and pasted from https://cello.shinyapps.io/kidneycellexplorer/. Although these data support the expression of Slc38a2 mRNA in medullary cells, I suggest to move them into Supplementary Data.</p></disp-quote><p>Thank you for the constructive suggestion. In the revised manuscript, we have moved the Figure 8A-B into Supplementary Data as Figure 3—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>Figure 8C. Detection of Slc38a2 protein in proximal tubules is surprising and non-consistent with the single cell sequencing data presented in Figure 8A and B. Is this staining specific or background? Control staining with secondary AB only would address this question.</p></disp-quote><p>Thank you for the valuable comments and suggestions. We routinely used non-specific IgG as a negative control. The results showed that staining for SLC38A2 protein was specific (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). The detection of SLC38A2 protein in the proximal tubules appears not to be consistent with the finding presented in Figure 8A and B (Figure 3—figure supplement 1 in the revised manuscript) in which the single cell sequencing data showed a very low mRNA level of <italic>Slc38a2</italic> in this renal tubular segment. The reason for this inconsistence is not clear. We speculate that some post-transcriptional and post-translational mechanisms may be involved in the regulation of the stability of SLC38A2 mRNA and protein. This important issue warrants further investigation.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Intrarenal localisation of SLC38A2 protein in the kidney.</title><p>Immunohistochemical study indicating intrarenal localisation of SLC38A2 protein in mouse. The results showed that SLC38A2 was expressed at relatively high level in the proximal tubule, thick ascending limb, and collecting duct, with low expression in the distal tubule. AQP1, THP, NCC, AQP2 are markers for the proximal tubule, distal tubule, thick ascending limb and collecting duct, respectively. IgG was used as a negative control.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-sa2-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Figure 9M: Increased TUNEL staining is suggested to be present in renal medullas of Slc38a2 knockout mice compared to control mice. This is an important finding. However, only two images of fluorescent stainings are presented. TUNEL positive cells should be quantitated and evaluated statistically.</p></disp-quote><p>Thank you for the valuable suggestion. As the reviewer suggested, the TUNEL positive cells have been quantitated and evaluated statistically. The results are now included in Figure 4N in the revised manuscript (Figure 9M in the original paper).</p><disp-quote content-type="editor-comment"><p>Figure S9: Knockout mice excrete slightly increased urinary volume, but at the same time they display increased urinary osmolarity. This combination of findings is surprising and unexpected. Does this mean that knockout mice excrete more osmolytes than control mice? I would have expected equal osmolyte excretion rates. The authors should discuss this finding.</p></disp-quote><p>Thank you for the constructive comment and suggestion. As shown in Figure S9 (Figure 4—figure supplement 2 in the revised manuscript), the <italic>Slc38a2</italic>-knockout mice indeed excreted slightly increased urinary volume. As described in the manuscript, SLC38A2 is an important neutral amino acid transporter in vivo and amino acids can serve as important osmolytes. We measured urine osmolyte and amino acid excretion in both wild-type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice. The results showed that daily osmolyte and amino acid excretion in the <italic>Slc38a2</italic>-KO mice was significantly higher than that in WT mice (<xref ref-type="fig" rid="sa2fig3">Author response image 3A</xref> and B), suggesting a slight increase in urinary osmolality. It is speculated that as an amino acid transporter, <italic>Slc38a2</italic>-gene deficiency results in blunted cellular uptake of certain amino acids by peripheral tissues and elevated level of amino acids in the plasma, which causes a mild osmotic diuresis. In addition, under dehydrate condition, increased collecting duct ferroptosis as reported in this paper may also contribute to increased urine output in the <italic>Slc38a2</italic>-knockout mice. In the revised manuscript, we briefly discussed this important issue.</p><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Daily urinary excretion of osmotic solutes and amino acids was increased in the Slc38a2- KO mice.</title><p>(A) Urine was collected from wild type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice (8-10 weeks old, male) for 24 h in the urine metabolic cage. The <italic>Slc38a2</italic>-KO mice exhibited more urine osmolyte excretion than WT mice. Urine osmotic pressure and urine volume were used to detect urine osmotic solutes (urine volume multiplied by urine osmotic pressure). (B) The <italic>Slc38a2</italic>-KO mice excreted more total amino acids in the urine than WT mice. Total Amino Acids (T-AA) Colorimetric Assay Kit was used to measure total amino acids in mouse urine (Elabscience, K055-M). Data are means ± SEM; two-tailed Student’s t test was used. P&lt;0.01, n=6-9.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-sa2-fig3-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Reviewer #3. Show the functional significance of SLC38A2 in vivo by comparing the long-term effects of water deprivation (with and without mTor inhibitor) of WT and ko-mice.</p></disp-quote><p>Thank the reviewer for the meaningful suggestion. Since long-term water deprivation is very harmful for experimental animals (PMID: 31818909; PMID: 17536615), the Animal Ethics Committee only allowed us to extend the period of water deprivation (WD) to 48 hours. Wild-type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice were divided into following groups: WT-WD-vehicle (n=9), KO-WD-vehicle (n=7), WT-WD-rapamycin (n=11), and KO-WD-rapamycin (n=8). The mice were intraperitoneally injected with rapamycin (2mg/kg/day) or vehicle (saline) for 7 consecutive days and were subjected to 2-day water deprivation staring from the fifth day. The results showed that both WT and KO mice receiving saline treatment can tolerate 2-day water restriction. However, in the presence of rapamycin, almost all KO mice were dead after 2-day water deprivation. Although WT mice survived 7-day rapamycin treatment and 2-day water restriction, all of them were in serious health condition. Therefore, we decided to terminate the experiment and could not complete the study. However, the findings further provided evidence supporting the importance of SLC38A2 (SLC38A2) in maintaining water homeostasis.</p><disp-quote content-type="editor-comment"><p>Explain Tubular gain of function (i.e. increased urine osmolality) with SLC38A2 ko.</p></disp-quote><p>Thank you for the meaningful comment. It is well known that SLC38A2 is an important neutral amino acid transporter in vivo and amino acids can serve as important osmolytes. We measured urine osmolyte and amino acid excretion in both wild-type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice. The results showed that daily osmolyte and amino acid excretion in the <italic>Slc38a2</italic>-KO mice was significantly higher than that in WT mice (<xref ref-type="fig" rid="sa2fig3">Author response image 3A</xref> and B), suggesting a slight increase in urinary osmolality. As an amino acid transporter, <italic>Slc38a2</italic>-gene deficiency results in blunted cellular uptake of certain amino acids by peripheral tissues and elevated levels of amino acids in the plasma (data not shown), which causes a mild osmolytic diuresis. Therefore, we speculate that increased urine osmolyte excretion may be due to increased glomerular filtration of amino acids into renal tubules, rather than a result of tubular gain of function. In the present study, we provide clear evidence that under dehydrate condition, collecting duct cell ferroptosis was significantly higher in the <italic>Slc38a2</italic>-knockout mice than that in wild-type cells. In the revised manuscript, we briefly discussed this important issue.</p><disp-quote content-type="editor-comment"><p>Electron microscopic evidence for ferroptosis in vivo.</p></disp-quote><p>Thank you for this important comment. As the reviewer suggested, we conducted an electron microscopic study on renal medullas of wild-type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice with 24-hour water deprivation. The results showed although both genotypes exhibited robust changes in mitochondrial morphology, the reduction of mitochondria volume and loss and rupture of mitochondrial crest were more severe in medullary cells of the KO mice than that in WT mice under water deprivation condition, which was in line with the findings in cultured cells under hyperosmolarity. Therefore, both in vitro and in vivo studies demonstrate that hyperosmolarity can aggravate medullary cell ferroptosis (<xref ref-type="fig" rid="sa2fig4">Author response image 4</xref>).</p><fig id="sa2fig4" position="float"><label>Author response image 4.</label><caption><title>Electron microscope examination showed that ferroptosis of renal medullary cells was aggravated in the <italic>Slc38a2</italic>-KO mice under water deprivation condition.</title><p>The renal medullas of mice were collected and analyzed by electron microscope after 24-h water deprivation. Representative images showed that more severe medullary cell ferroptosis as reflected by the reduction of mitochondria volume and loss and rupture of mitochondrial crest (arrows) was found in the KO mice than that in WT mice under water deprivation. Scale bar = 0.5μm. WD: water deprivation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-sa2-fig4-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Explain: mOsmo -SLC38A2/NFkB dose response in IMCD3 cells in vivo.</p></disp-quote><p>Thanks for the valuable comment. We guess the reviewer means dose response in mIMCD3 in vitro, since mIMCD3 is a mouse collecting duct cell line. It has been well known that NF-κB as a transcription factor plays an important role in promoting the survival of the collecting duct cells. A recent study (PMID: 32175843) showed that the induction of SLC38A2 (SLC38A2) is mediated by the nuclear factor κB (NF-κB) family protein, which is consistent with our findings. In the mIMCD3 cells, we found a dose-dependent response of active NF-κB (p-NF-κB) to osmotic pressure between 300 mOsm and 800 mOsm (Figure 6A). However, in terms of SLC38A2, we only observed a dose-dependent response of SLC38A2 protein between 300 mOsm and 600 mOsm (Figure 5B). The reason for the inconsistence remains unclear. One possibility is that the half-life of SLC38A2 protein is shorter than that of NF-κB protein. The other possibility is that the effect of NF-κB on SLC38A2 expression is dependent on the NF-κB activity. At low level NF-κB induces SLC38A2 expression, while at high level it suppresses SLC38A2 expression. However, the precise mechanism by which NF-κB affects SLC38A2 expression requires further investigation.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>These studies address the mechanisms by which medullary collecting duct cells survive the rigors of periodic medullary hypertonicity which is needed for urinary concentration. The authors make a convincing case that hypertonicity leads to upregulation of the nF-kappaB pathway, which drives synthesis of the amino acid transporter, SLC38A2, which in turn provides critical amino acid substrates for the synthesis of the oxygen scavenger, glutathione. The studies combine work in cell lines, primary cultures and in the intact mouse. The work starts with an unbiased RNASeq approach which identified the upregulation of the SLC38A2 gene, and the authors then examine, systematically the role of upregulation of SLC38A2 in cell survival, and the pathways involved in SLC38A2 regulation. The studies are convincing and well performed.</p><p>I have only a few comments, which might improve the presentation.</p><p>1. Towards the end of the Results the authors turn to the whole animal, showing that water deprivation upregulates SLC38A2 expression, and showing the localization of SLC38A2 on cell membranes. I might move from the RNASeq to a description of the in vivo results in mice, including the knockout studies. These establish the importance of SLC38A2 in the intact mouse. I would then go on to use the cell culture studies to define the mechanisms involved.</p></disp-quote><p>Thank you for this important comment. According to your suggestion, we reorganized the paper by showing in vivo results first and then in vitro findings in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2. In the intact mouse, does hypertonicity activate nF-KappaB (upstream stimulator of SLC38A2 synthesis) or TORC1 (downstream pathway putatively upregulated by SLC38A2)?</p></disp-quote><p>Thanks for the meaningful question. In the present study, we found that in wild-type mice water deprivation upregulated the NF-κB pathway in renal medullas (please see Figure 6C in the revised manuscript), but downregulated the mTORC1 pathway (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) which is consistent with our in vitro finding.</p><disp-quote content-type="editor-comment"><p>3. The SLC38A2 -/- mouse has (p 22) polyuria and &quot;increased urine osmotic pressure.&quot; This term is unclear. Do the authors mean, hypotonic urine?</p></disp-quote><p>Thanks a lot for your careful reading and comment. Indeed, the term “increased urine osmotic pressure” is not appropriate. What we meant is that the SLC38A2-/- (<italic>Slc38a2<sup>-/-</sup></italic>) mice exhibited increased urine osmolyte excretion. As described in the manuscript, SLC38A2 is an important neutral amino acid transporter in vivo and amino acids can serve as important osmolytes. We measured urine osmolyte and amino acid excretion in both wild-type (WT) and <italic>Slc38a2</italic>-knockout (KO) mice. The results showed that daily osmolyte and amino acid excretion in the <italic>Slc38a2</italic>-KO mice was significantly higher than that in WT mice, suggesting a slight increase in urinary osmolality. We have corrected the term in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors use a mouse inner medullary collecting duct cell line (mIMCD-3), primary mouse medullary collecting duct (MCD) cells and a genetic mouse model to provide evidence that</p><p>(1) Hyperosmolarity induces cell death in mIMCD-3 cells that displays features of ferroptosis (lipid peroxidation, inhibition by ferroptosis inhibitors, potentiation by ferroptosis inducers)</p><p>(2) Slc38a2 (=SLC38A2), a previously identified neutral amino acid transporter providing substrates for intracellular glutathion (GSH) production, is strongly induced by high osmolarity in mIMCD-3 and primary MCD cells.</p><p>(3) Activation of nuclear factor kappa B (NF-kappaB) in response to hyperosmolarity is an important upstream regulator of Slc38a2 in mIMCD-3 cells.</p><p>(4) Overexpression of Slc38a2 by adenovirus inhibits ferroptosis and that inhibition or downregulation of Slc38a2 aggravates hypertonicity-induced ferroptosis in mIMCD3 and primary IMCD cells.</p><p>(5) Slc38a2 inhibits ferroptosis under hypertonic stress in mIMCD-3 cells by activating mTOR signaling.</p><p>(6) Slc38a2 is expressed in medullary epithelial cells of the mouse nephron and its mRNA and protein is induced in response to water deprivation.</p><p>(7) Water deprived Slc38a2 knockout mice display evidence of ferroptotic cell death in the renal medulla.</p><p>Strengths:</p><p>The study is thoroughly conducted and presented well.</p><p>Extensive in vitro studies are provided using a mouse inner medullary collecting duct cell line and primary mouse medullary collecting duct cells.</p><p>Novel molecular insights into hyperosmolarity-induced regulation of Slc38a2 in collecting duct cells are provided.</p><p>Novel molecular insights into the relationship of Slc38a2 and the prevention of ferroptosis in collecting duct cells are provided.</p></disp-quote><p>in vivo <italic>evidence from Slc38a2 knockout mice largely supports the</italic> in vitro <italic>findings.</italic></p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>No major weaknesses are identified.</p><p>Conclusion:</p><p>The authors provide important and novel information on the molecular basis of osmotic resistance in the renal medulla. The results are carefully presented and interpreted. The data will be important to the field of renal physiology and might be of relevance to the molecular basis of human disease.</p></disp-quote><p>We appreciate the reviewer for the positive comments on our present work.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>In their Du et al. describe that hypertonicity induces regulated cell death of IMCD3 and primary renal medullary collecting cells via ferroptosis. They show that hypertonicity induces the neutral amino acid transporter SLC38A2 in these cells and conversely that SLC38A2 depletion or inhibition further increase ferroptosis. These findings are paralleled by in vivo studies showing induction of SLC38A2 in medullary collecting cells and other tubule segments and increased TUNEL signal following water dehydration.</p><p>Strengths:</p><p>The authors put up a model explaining the role of SLC38A2 in the protection of IMCD3 and primary renal medullary collecting cells against hypertonicity, which is supported by the effects of SLC38A2 induction by hypertonicity (mRNA and protein level) in the above cells in vitro. It is further supported by the use of various inhibitors and enhancers of ferroptosis. The authors also show induction of SLC38A2 by NFkB. in vivo, tubular (including IMC ducts) SLC38A2 expression is induced by water deprivation, which is in line with their model. Increased numbers of TUNEL positive cells are observed in SLC38A2 ko mice, consistent with their in vitro data and their model.</p><p>Weakness:</p><p>The authors demonstrate maximal induction of SLC38A2 mRNA and protein and 600 mOsm. However, they also show declining levels SLC38A2 mRNA and protein at 700 and 800 mOsm (Figure 3). The authors only describe the time course of induction but not describe the dose response curve. As urine osmolality can go much higher the question arises why SLC38A2 should be considered protective when its is not expressed in IMCD3 cells with 700 mOsm and higher. So what is the role of SLC38A2 above 600 mOsm?</p></disp-quote><p>Thank the reviewer for the meaningful comment. The mIMCD3 is a mouse inner medullary collecting duct cell line which is commonly used for studying the collecting duct function in vitro. The mIMCD3 cells were usually cultured in isotonic medium, which is in sharp contrast to medullary collecting duct cells in the kidney who live in a hypertonic and hypoxic environment. In addition, as a transformed cells, mIMCD3 cells loss many characteristics of renal medullary collecting duct cells. As a result, mIMCD3 cells can only tolerate hypertonicity up to 600 mOsm. In the hypertonic medium with 700 mOsm and higher, most of mIMCD3 cells are dead, leading to the degradation of most of proteins including SLC38A2 (SLC38A2). As the reviewer pointed out, urine and medullary osmolality can go much higher under dehydration condition. To better mimic the in vivo characteristics of medullary collecting duct cells, we also cultured primary renal collecting duct cells who can tolerate much higher osmolality. As shown in Figure 8E in the revised manuscript, SLC38A2 protein expression remains at high level under 1200 mOsm. Therefore, as described in the manuscript, SLC38A2 has an important protective effect on the survival of medullary cells under hypertonic conditions above 600 mOsm in vivo.</p><disp-quote content-type="editor-comment"><p>Figure S3: Induction of Slco4a1 and Slc5a3 mRNA was much stronger with hyperosmolality compared to the effect on Slc38a2 mRNA. Can the authors exclude a role of the former in protection against hyperosmolality?</p></disp-quote><p>The reviewer raised an important point. In the kidney, the protective role of <italic>Slc5a3</italic> against hypertonic stress has been repeatedly reported (PMID: 7948784; PMID: 8430828; PMID: 9685419). In terms of <italic>Slco4a1</italic>, although many reports demonstrate a role in tumorigenesis, its role in osmoprotection in the kidney remains largely unknown and is currently under investigation in our group.</p><disp-quote content-type="editor-comment"><p>Figure 4: The authors do not explain why they study NFkB. They show that hypertonicity dose-dependently increased NF-κB activity in mIMCD3 cells from 300-800 mOsm. How do the authors reconcile this notion with repression of SLC38A2 expression with 700 and 800 mOsm (Figure 3.)?</p></disp-quote><p>Thanks for the wonderful comment. It has been well known that NF-κB as a transcription factor plays an important role in promoting the survival of the collecting duct cells. A recent study (PMID: 32175843) showed that the induction of SLC38A2 (SLC38A2) is mediated by the nuclear factor κB (NF-κB) family protein, which is consistent with our findings. In the mIMCD3 cells, we found a dose-dependent response of active NF-κB (p-NF-κB) to osmotic pressure between 300 mOsm and 800 mOsm (Figure 6A). However, in terms of SLC38A2, we only observed a dose-dependent response of SLC38A2 protein between 300 mOsm and 600 mOsm (Figure 5B). The reason for the inconsistence remains unclear. One possibility is that the half-life of SLC38A2 protein is shorter than that of NF-κB protein. The other possibility is that the effect of NF-κB on SLC38A2 expression is dependent on the NF-κB activity. At low level NF-κB induces SLC38A2 expression, while at high level it suppresses SLC38A2 expression. However, the precise mechanism by which NF-κB affects SLC38A2 expression requires further investigation.</p><disp-quote content-type="editor-comment"><p>Figure 9: Can the authors provide independent evidence for ferroptosis by performing electron microscopic studies of renal medullae?</p></disp-quote><p>Thank you for this important comment. As the reviewer suggested, we conducted an electron microscopic study on renal medullas of wild-type (WT) and the <italic>Slc38a2</italic>-knockout (KO) mice with 24-hour water deprivation. The results showed that although both genotypes exhibited robust changes in mitochondrial morphology, the reduction of mitochondria volume and loss and rupture of mitochondrial crest were more severe in renal medullary cells of the KO mice than that in WT mice under water deprivation condition, which was in line with the findings in cultured cells under hyperosmolarity. Therefore, both in vitro and in vivo studies demonstrate that hyperosmolarity can aggravate renal medullary cell ferroptosis (<xref ref-type="fig" rid="sa2fig4">Author response image 4</xref>).</p><disp-quote content-type="editor-comment"><p>Figure S9: The authors demonstrate increased urine osmolality in SLC38A2 ko mice (despite higher urine output). How do the authors explain the obviously increased medullary osmotic gradient?</p></disp-quote><p>Thank you for the constructive comment and suggestion. As shown in Figure S9 (Figure 4—figure supplement 2 in the revised manuscript), the <italic>Slc38a2</italic>-knockout mice indeed excreted slightly increased urinary volume. As described in the manuscript, SLC38A2 is an important neutral amino acid transporter in vivo and amino acids can serve as important osmolytes. We measured urine osmolyte and amino acid excretion in both wild-type (WT) and <italic>Slc38a2</italic>-knockout (KO) mice. The results showed that daily osmolyte and amino acid excretion in the <italic>Slc38a2</italic>-KO mice was significantly higher than that in WT mice (<xref ref-type="fig" rid="sa2fig3">Author response image 3A</xref> and B), suggesting a slight increase in urinary osmolality. It is speculated that as an amino acid transporter, <italic>Slc38a2</italic>-gene deficiency results in blunted uptake of certain amino acids by peripheral tissues and elevated level of amino acids in the plasma, which causes a mild osmotic diuresis. In addition, under dehydrate condition, increased collecting duct ferroptosis as reported in this paper may also contribute to increased urine output in the <italic>Slc38a2</italic>-knockout mice. In terms of medullary osmotic gradient, we speculate that it is slightly reduced due to massive ferroptosis of medullary collecting duct cells in the <italic>Slc38a2</italic>-knockout mice after dehydration. In the revised manuscript, we briefly discussed this important issue.</p><disp-quote content-type="editor-comment"><p>How do the authors explain the &quot;polyuria&quot; under basal (S9b) and challenged conditions (S9e).</p></disp-quote><p>Thanks a lot for your careful reading and meaningful question. It is speculated that as an amino acid transporter, <italic>Slc38a2</italic>-gene deficiency results in blunted cellular uptake of certain amino acids by peripheral tissues and elevated level of amino acids in the plasma, which causes a mild osmotic diuresis. In addition, under dehydrate condition, increased collecting duct ferroptosis as reported in this paper may also contribute to increased urine output in the <italic>Slc38a2</italic>-knockout mice.</p><disp-quote content-type="editor-comment"><p>Significantly increased cell death should rather decrease but not increase the medullary osmotic gradient at least during longer term experiments. Such experiments (maybe combined with Tor-inhibitors) may yield insight into the functional role of SLC38A2 in water deprived animals.</p></disp-quote><p>Thank the reviewer for the meaningful suggestion. Since long-term water deprivation is very harmful for experimental animals (PMID: 31818909; PMID: 17536615), the Animal Ethics Committee only allowed us to extend the period of water deprivation (WD) to 48 hours. Wild-type (WT) and <italic>Slc38a2</italic>-knockout (KO) mice were divided into following groups: WT-WD-vehicle (n=9), KO-WD-vehicle (n=7), WT-WD-rapamycin (n=11), and KO-WD-rapamycin (n=8). The mice were intraperitoneally injected with rapamycin (2mg/kg/day) or vehicle (saline) for 7 consecutive days and were subjected to 2-day water deprivation staring from the fifth day. The results showed that both WT and KO mice receiving saline treatment can tolerate 2-day water restriction. However, in the presence of rapamycin, almost all KO mice were dead after 2-day water deprivation. Although WT mice survived 7-day rapamycin treatment and 2-day water restriction, all of them were in serious health condition. Therefore, we decided to terminate the experiment but could not complete the study. However, the findings further provided evidence supporting the importance of SLC38A2 (SLC38A2) in maintaining water homeostasis.</p><disp-quote content-type="editor-comment"><p>In the discussion, the authors state: &quot;Finally, by using SLC38A2 gene knockout mice, we confirm the critical role of SLC38A2 in maintaining renal medullary homeostasis and renal urine concentration by attenuating medullary cell ferroptosis.&quot; The increased urine osmolality in SLC38A2 ko mice indicates the opposite.</p></disp-quote><p>Thank you for the valuable comment. In the present study, we showed that the <italic>Slc38a2</italic> (SLC38A2) gene knockout (KO) aggravated ferroptosis of medullary collecting duct cells, leading to an impaired urine concentration and increased urine output. The increased urine osmolyte excretion is possibly due to enhanced glomerular filtration of amino acids into renal tubules as a results of elevated plasma amino acid levels (data not shown). Another possibility is that <italic>Slc38a2</italic>-gene deficiency in renal tubules reduced the capacity of renal reabsorption of the filtrated amino acids, resulting in a slight increase in urine osmolality and mild osmotic diuresis.</p><disp-quote content-type="editor-comment"><p>The authors use different osmolarities ranging between 300-1200 mOsm without explaining why. (i.e. Figure 1a-c with 300 and 600 mOSM vs. With 300 and 500 mOSM in Figure 1d-f).</p></disp-quote><p>Thanks for your meaningful question. The mIMCD3 is a mouse inner medullary collecting duct cell line which is commonly used for studying the collecting duct function in vitro. The mIMCD3 cells were usually cultured in isotonic medium, which is in sharp contrast to medullary collecting duct cells in the kidney who live in a hypertonic and hypoxic environment. In addition, as a transformed cells, mIMCD3 cells loss many characteristics of renal medullary collecting duct cells after many passages. As a result, mIMCD3 cells can only tolerate hypertonicity up to 600 mOsm and in the hypertonic medium with 700 mOsm and higher, most of mIMCD3 cells are dead. As the reviewer mentioned, urine and medullary osmolality can go much higher in vivo under dehydration condition. To better mimic the in vivo characteristics of medullary collecting duct cells, we also cultured primary renal collecting duct cells who can tolerate much higher osmolality, which allowed us to determine the effect of higher osmotic pressure (up to 1200 mOsm) on these cells.</p><p>As mentioned above, the mIMCD3 cells are more suitable for testing the effect of osmolality between 300 mOsm and 800 mOsm. Since hypertonicity causes ferroptosis of mIMCD3 cells in a dose dependent manner, we chose 600 mOsm to determine the protective effect of the ferroptosis inhibitor and 500 mOsm to measure injurious effect of the ferroptosis agonist.</p><disp-quote content-type="editor-comment"><p>Figure 9 M: Can the authors localize TUNEL-positivity to either interstitial and/or tubular cells?</p></disp-quote><p>Thank you for the constructive comment. As the reviewer suggested, we co-stained TUNEL positive cells with AQP2, a marker for renal collecting duct cells. The results showed that the cells with positive tunnel staining (green) were co-localized with the collecting duct marker AQP2 (red) in renal medulla (<xref ref-type="fig" rid="sa2fig5">Author response image 5</xref>). This finding demonstrates that the TUNEL positive cells were mainly the medullary collecting ducts rather than interstitial cells.</p><fig id="sa2fig5" position="float"><label>Author response image 5.</label><caption><title>Increased TUNEL-positive cells in renal medullary collecting duct cells of the <italic>Slc38a2</italic>-KO mice after water deprivation.</title><p>Immunofluorescence analysis showing that water restriction resulted in a marked increase in cell death (green) in the medullas of the <italic>Slc38a2-/-</italic> mice as assessed by the TUNEL assay. TUNEL staining (green) and AQP2 (red) staining showed that the TUNEL-positive cells were mainly renal medullary collecting ducts. AQP2: Aquaporin 2, a marker of renal collecting duct cells. WT: wild-type; KO: <italic>Slc38a2-/-</italic>; WD: water deprivation. Scale bar=25μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80647-sa2-fig5-v2.tif"/></fig></body></sub-article></article>